RU2016141308A - Обнаружение мутаций и плоидности в хромосомных сегментах - Google Patents
Обнаружение мутаций и плоидности в хромосомных сегментах Download PDFInfo
- Publication number
- RU2016141308A RU2016141308A RU2016141308A RU2016141308A RU2016141308A RU 2016141308 A RU2016141308 A RU 2016141308A RU 2016141308 A RU2016141308 A RU 2016141308A RU 2016141308 A RU2016141308 A RU 2016141308A RU 2016141308 A RU2016141308 A RU 2016141308A
- Authority
- RU
- Russia
- Prior art keywords
- sample
- individual
- polymorphic loci
- probabilities
- allele
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N7/00—Computing arrangements based on specific mathematical models
- G06N7/01—Probabilistic graphical models, e.g. probabilistic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2539/00—Reactions characterised by analysis of gene expression or genome comparison
- C12Q2539/10—The purpose being sequence identification by analysis of gene expression or genome comparison characterised by
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Theoretical Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Data Mining & Analysis (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Software Systems (AREA)
- General Engineering & Computer Science (AREA)
- Databases & Information Systems (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Immunology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Bioethics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Primary Health Care (AREA)
- General Physics & Mathematics (AREA)
- Computing Systems (AREA)
- Mathematical Physics (AREA)
Claims (75)
1. Способ определения плоидности хромосомного сегмента в образце индивидуума, предусматривающий:
a. получение данных о частоте аллелей, сгенерированных из образца, содержащих количество каждого аллеля, присутствующего в образце, в каждом локусе в совокупности полиморфных локусов на хромосомном сегменте;
b. создание фазированной аллельной информации для совокупности полиморфных локусов путем оценки фазы данных о частоте аллелей;
c. создание индивидуальных вероятностей частот аллелей для полиморфных локусов для различных состояний плоидности с использованием данных о частоте аллелей, где индивидуальные вероятности получают с использованием совокупности моделей, как различных состояний плоидности, так и фракций аллельного дисбаланса для совокупности полиморфных локусов;
d. создание совместных вероятностей для совокупности полиморфных локусов с использованием индивидуальных вероятностей и фазированной аллельной информации и учет взаимосвязи между полиморфными локусами на хромосомном сегменте; а также
e. выбор, основанный на совместных вероятностях, наиболее подходящей модели, указывающей на хромосомную плоидность, тем самым определяя плоидность хромосомного сегмента, где образец представляет собой образец крови, образец плазмы или образец сыворотки от индивидуума, у которого подозревают наличие злокачественной опухоли, и способ дополнительно предусматривает определение на основании выбора того, присутствует ли в клетках опухоли индивидуума вариация числа копий.
2. Способ по п. 1, при котором данные о частоте аллелей получают из данных о последовательности нуклеиновых кислот.
3. Способ по п. 1, дополнительно предусматривающий стадию исправления ошибок в данных о частоте аллелей и использование исправленных данных о частоте аллелей для создания стадии индивидуальных вероятностей, где исправляемые ошибки представляют собой систематические ошибки эффективности амплификации аллелей.
4. Способ обнаружения хромосомной плоидности в образце индивидуума, предусматривающий:
a. получение данных о последовательности нуклеиновой кислоты, сгенерированных из образца, для аллелей в совокупности полиморфных локусов на хромосомном сегменте у индивидуума;
b. обнаружение частот аллелей в совокупности локусов с использованием данных о последовательностях нуклеиновых кислот;
c. коррекция систематических ошибок эффективности амплификации аллелей в обнаруженных частотах аллелей для получения скорректированных частот аллелей для совокупности полиморфных локусов;
d. создание фазированной аллельной информации для совокупности полиморфных локусов путем оценки фазы данных о последовательностях нуклеиновых кислот;
e. создание индивидуальных вероятностей частот аллелей для полиморфных локусов для различных состояний плоидности путем сравнения скорректированных частот аллелей с совокупностью моделей различных состояний плоидности и фракций аллельного дисбаланса совокупности полиморфных локусов;
f. создание совместных вероятностей для совокупности полиморфных локусов путем объединения индивидуальных вероятностей с учетом связи между полиморфными локусами на хромосомном сегменте; а также
g. выбор, основанный на совместных вероятностях, наиболее подходящей модели, указывающей на хромосомную плоидность, где образец представляет собой образец крови, образец плазмы или образец сыворотки от индивидуума, у которого подозревают наличие злокачественной опухоли, и способ дополнительно предусматривает определение на основании выбора того, присутствует ли в клетках опухоли индивидуума вариация числа копий.
5. Способ по любому из пп. 1-4, при котором индивидуальные вероятности создаются путем моделирования состояний плоидности первого гомолога хромосомного сегмента и второго гомолога хромосомного сегмента, причем состояния плоидности заключаются в том, что:
(1) все клетки характеризуются отсутствием делеции или амплификации первого гомолога или второго гомолога хромосомного сегмента;
(2) по меньшей мере некоторые клетки характеризуются наличием делеции первого гомолога или амплификации второго гомолога хромосомного сегмента; а также
(3) по меньшей мере некоторые клетки характеризуются наличием делеции второго гомолога или амплификации первого гомолога хромосомного сегмента.
6. Способ по п. 4, при котором ошибки, которые исправляются, содержат загрязнение от окружающей среды и загрязнение генотипа и определяются для гомозиготных аллелей в образце.
7. Способ по п. 4, при котором отбор осуществляется путем анализа величины разницы между фазированной аллельной информацией и расчетными частотами аллелей, полученными для моделей, и выбирается модель с меньшей величиной разницы.
8. Способ по любому из пп. 1-3, 4, 6 и 7, при котором индивидуальные вероятности частот аллелей
(i) получают на основании бета-биномиальной модели ожидаемых и наблюдаемых частот аллелей в совокупности полиморфных локусов; или
(ii) получают с использованием Байесовского классификатора.
9. Способ по любому из пп. 2 или 4, при котором данные о последовательности нуклеиновой кислоты получают посредством выполнения секвенирования ДНК с высокой пропускной способностью множества копий серий ампликонов, полученных с использованием мультиплексной реакции амплификации, причем каждый ампликон из серии ампликонов охватывает по меньшей мере один полиморфный локус совокупности полиморфных локусов и причем каждый из полиморфных локусов совокупности амплифицируется.
10. Способ по п. 9, при котором мультиплексную реакцию амплификации
(i) осуществляют в условиях ограниченного количества праймера; или
(ii) содержит от 1000 до 100000 мультиплексных реакций.
11. Способ по п. 9, при котором хромосомную плоидность определяют для совокупности хромосомных сегментов в образце.
12. Способ по любому из пп. 1-3, 4, 6 и 7, в котором средний аллельный дисбаланс, превышающий 0,45%, свидетельствует о присутствии в клетках опухоли индивидуума вариации числа копий.
13. Способ по любому из пп. 1-3, 4, 6 или 7, при котором образец представляет собой образец плазмы от индивидуума, у которого ранее имелась солидная опухоль.
14. Способ по пп. 1-3, 4, 6 или 7, дополнительно предусматривающий определение, представлен ли однонуклеотидный вариант в образце в целевой совокупности однонуклеотидных вариантов, причем обнаружение либо вариации числа копий, либо однонуклеотидного варианта, либо и того и другого указывает на наличие циркулирующих опухолевых нуклеиновых кислот в образце.
15. Способ по п. 13, дополнительно предусматривающий получение информации о гаплотипе хромосомного сегмента для опухоли индивидуума и использование информации о гаплотипе для создания совокупности моделей различных состояний плоидности и фракций аллельного дисбаланса совокупности полиморфных локусов.
16. Способ по любому из пп. 1-3, 4, 6 или 7, при котором способ дополнительно предусматривает
(i) стадию удаления выбросов из скорректированных данных о частоте аллеля перед сравнением скорректированных частот аллелей с совокупностью моделей; или
(ii) реализацию способа на контрольном образце с известным средним соотношением аллельного дисбаланса.
17. Система для определения хромосомной плоидности в образце индивидуума, содержащая:
a. входной процессор, выполненный с возможностью приема данных о частоте аллелей, сгенерированных из образца, содержащих количество каждого аллеля, присутствующих в образце в каждом локусе в совокупности полиморфных локусов на хромосомном сегменте;
b. моделирующее устройство, выполненное с возможностью:
I. создавать фазированную аллельную информацию для совокупности полиморфных локусов путем оценки фазы данных о частоте аллелей; а также
II. создавать индивидуальные вероятности частот аллелей для полиморфных локусов для различных состояний плоидности с использованием данных о частоте аллелей, где индивидуальные вероятности получают с использованием совокупности моделей, как различных состояний плоидности, так и фракций аллельного дисбаланса для совокупности полиморфных локусов; а также
III. создавать совместные вероятности для совокупности полиморфных локусов с использованием индивидуальных вероятностей и фазированной аллельной информации и учитывать взаимосвязь между полиморфными локусами на хромосомном сегменте; а также
c. менеджер гипотез, выполненный с возможностью выбирать, на основании совместных вероятностей, наиболее подходящую модель, указывающую на хромосомную плоидность, тем самым определяя плоидность хромосомного сегмента, где образец представляет собой образец крови, образец плазмы или образец сыворотки от индивидуума, у которого подозревают наличие злокачественной опухоли, и способ дополнительно предусматривает определение на основании выбора того, присутствует ли в клетках опухоли индивидуума вариация числа копий.
18. Система по п. 17, в которой данные о частоте аллелей создаются системой секвенирования нуклеиновых кислот.
19. Система по п. 18, дополнительно предусматривающая блок коррекции ошибок, выполненный с возможностью исправления ошибок в данных о частоте аллелей, причем исправленные данные о частоте аллелей используются для создания стадии индивидуальных вероятностей и причем ошибки, которые исправляют, представляют собой эффективность амплификации аллеля.
20. Система для определения хромосомной плоидности в образце индивидуума, содержащая:
a. входной процессор, выполненный с возможностью приема данных о последовательности нуклеиновой кислоты, сгенерированных из образца, для аллелей в совокупности полиморфных локусов на хромосомном сегменте у индивидуума, и обнаружения частоты аллелей в совокупности локусов с использованием данных о последовательности нуклеиновой кислоты;
b. блок коррекции ошибок, выполненный с возможностью исправления ошибок в обнаруженных частотах аллелей и создания скорректированных частот аллелей для совокупности полиморфных локусов;
c. моделирующее устройство, выполненное с возможностью:
I. создавать фазированную аллельную информацию для совокупности полиморфных локусов путем оценки фазы данных о последовательности нуклеиновой кислоты;
II. создавать индивидуальные вероятности частот аллелей для полиморфных локусов для различных состояний плоидности путем сравнения фазированной аллельной информации с совокупностью моделей различных состояний плоидности и фракций аллельного дисбаланса совокупности полиморфных локусов; а также
III. создавать совместные вероятности для совокупности полиморфных локусов путем объединения индивидуальных вероятностей с учетом относительного расстояния между полиморфными локусами на хромосомном сегменте; а также
d. менеджер гипотез, выполненный с возможностью выбора, основанного на совместных вероятностях, наиболее подходящей модели, указывающей на хромосомную анеуплоидию, где образец представляет собой образец крови, образец плазмы или образец сыворотки от индивидуума, у которого подозревают наличие злокачественной опухоли, и способ дополнительно предусматривает определение на основании выбора того, присутствует ли в клетках опухоли индивидуума вариация числа копий.
21. Система по п. 20, в которой менеджер гипотез выбирает путем анализа величины разницы между фазированной аллельной информацией и расчетными частотами аллелей, созданными для моделей и выбирает модель с меньшей величиной разницы.
22. Система по п. 21, в которой моделирующее устройство создает индивидуальные вероятности частот аллелей на основе бета-биномиальной модели ожидаемых и наблюдаемых частот аллелей в совокупности полиморфных локусов.
23. Энергонезависимый машиночитаемый носитель для обнаружения хромосомной плоидности в образце индивидуума, содержащий машиночитаемый код, который, когда он выполняется устройством обработки данных, приводит к тому, что устройство обработки данных:
a. получает данные о частоте аллелей, сгенерированные из образца, содержащие количество каждого аллеля, присутствующего в образце в каждом локусе в совокупности полиморфных локусов на хромосомном сегменте;
b. создает фазированную аллельную информацию для совокупности полиморфных локусов путем оценки фазы данных о частоте аллелей;
c. создает индивидуальные вероятности частот аллелей для полиморфных локусов для различных состояний плоидности с использованием данных о частоте аллелей, где индивидуальные вероятности получают с использованием совокупности моделей, как различных состояний плоидности, так и фракций аллельного дисбаланса для полиморфных локусов;
d. создает совместные вероятности для совокупности полиморфных локусов с использованием индивидуальных вероятностей и фазированной аллельной информации и учитывает взаимосвязь между полиморфными локусами на хромосомном сегменте; а также
e. выбирает, основываясь на совместных вероятностях, наиболее подходящую модель, указывающую на хромосомную плоидность, определяя тем самым плоидность хромосомного сегмента, где образец представляет собой образец крови, образец плазмы или образец сыворотки от индивидуума, у которого подозревают наличие злокачественной опухоли, и способ дополнительно предусматривает определение на основании выбора того, присутствует ли в клетках опухоли индивидуума вариация числа копий.
24. Машиночитаемый носитель в соответствии с п. 23, в котором данные о частоте аллелей получают из данных о последовательностях нуклеиновых кислот.
25. Машиночитаемый носитель в соответствии с п. 23, дополнительно предусматривающий исправление ошибок в данных о частоте аллелей и использование исправленных данных о частоте аллелей для создания стадии индивидуальных вероятностей, где ошибки, которые исправляются, представляют собой систематические ошибки эффективности амплификации аллелей.
26. Энергонезависимый машиночитаемый носитель для обнаружения хромосомной плоидности в образце индивидуума, содержащий машиночитаемый код, который, когда он выполняется устройством обработки данных, приводит к тому, что устройство обработки данных:
a. получает данные о последовательности нуклеиновой кислоты, сгенерированные из образца, для аллелей в совокупности полиморфных локусов на хромосомном сегменте у индивидуума;
b. обнаруживает частоты аллелей в совокупности локусов с использованием данных о последовательностях нуклеиновых кислот;
c. корректирует систематические ошибки эффективности амплификации аллелей в обнаруженных частотах аллелей для получения скорректированных частот аллелей для совокупности полиморфных локусов;
d. создает фазированную аллельную информацию для совокупности полиморфных локусов путем оценки фазы данных о последовательностях нуклеиновых кислот;
e. создает индивидуальные вероятности частот аллелей для полиморфных локусов для различных состояний плоидности путем сравнения скорректированных частот аллелей с совокупностью моделей различных состояний плоидности и фракций аллельного дисбаланса совокупности полиморфных локусов;
f. создает совместные вероятности для совокупности полиморфных локусов путем объединения индивидуальных вероятностей с учетом связи между полиморфными локусами на хромосомном сегменте; а также
g. выбирает основанную на совместных вероятностях наиболее подходящую модель, указывающую на хромосомную анеуплоидию, где образец представляет собой образец крови, образец плазмы или образец сыворотки от индивидуума, у которого подозревают наличие злокачественной опухоли, и способ дополнительно предусматривает определение на основании выбора того, присутствует ли в клетках опухоли индивидуума вариация числа копий.
27. Машиночитаемый носитель по п. 26, в котором выбор осуществляется путем анализа величины разницы между фазированной аллельной информацией и расчетными частотами аллелей, создаваемые для моделей, и выбирается модель с меньшей величиной разницы.
28. Машиночитаемый носитель по любому из пп. 23-25 и 26, в котором индивидуальные вероятности частот аллелей создаются на основании бета-биномиальной модели ожидаемой и наблюдаемой частот аллелей в совокупности полиморфных локусов.
29. Способ по любому из пп. 2-3, 4, 6 или 7, дополнительно предусматривающий определение, представлен ли однонуклеотидный вариант в образце в целевой совокупности однонуклеотидных вариантов, причем обнаружение либо вариации числа копий, либо однонуклеотидного варианта, либо и того и другого указывает на наличие циркулирующих опухолевых нуклеиновых кислот в образце, данные о последовательности нуклеиновой кислоты получают посредством выполнения секвенирования ДНК с высокой пропускной способностью множества копий серий ампликонов, полученных с использованием мультиплексной реакции амплификации, причем каждый ампликон из серии ампликонов охватывает по меньшей мере один полиморфный локус совокупности полиморфных локусов и причем каждый из полиморфных локусов совокупности амплифицируется, и где образец крови, образец плазмы или образец сыворотки используется для определения, присутствует ли в клетках опухоли индивидуума вариация числа копий, или однонуклеотидная вариация, или и то и другое.
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461982245P | 2014-04-21 | 2014-04-21 | |
US61/982,245 | 2014-04-21 | ||
US201461987407P | 2014-05-01 | 2014-05-01 | |
US61/987,407 | 2014-05-01 | ||
US201461994791P | 2014-05-16 | 2014-05-16 | |
US61/994,791 | 2014-05-16 | ||
US201462066514P | 2014-10-21 | 2014-10-21 | |
US62/066,514 | 2014-10-21 | ||
US201562146188P | 2015-04-10 | 2015-04-10 | |
US62/146,188 | 2015-04-10 | ||
US201562147377P | 2015-04-14 | 2015-04-14 | |
US62/147,377 | 2015-04-14 | ||
US201562148173P | 2015-04-15 | 2015-04-15 | |
US62/148,173 | 2015-04-15 | ||
PCT/US2015/026957 WO2015164432A1 (en) | 2014-04-21 | 2015-04-21 | Detecting mutations and ploidy in chromosomal segments |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2016141308A true RU2016141308A (ru) | 2018-05-22 |
RU2016141308A3 RU2016141308A3 (ru) | 2018-11-19 |
RU2717641C2 RU2717641C2 (ru) | 2020-03-24 |
Family
ID=57221528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2016141308A RU2717641C2 (ru) | 2014-04-21 | 2015-04-21 | Обнаружение мутаций и плоидности в хромосомных сегментах |
Country Status (8)
Country | Link |
---|---|
US (13) | US10179937B2 (ru) |
EP (3) | EP3957749A1 (ru) |
JP (11) | JP6659575B2 (ru) |
CN (3) | CN113774132A (ru) |
AU (4) | AU2015249846B2 (ru) |
CA (1) | CA2945962C (ru) |
HK (1) | HK1232260A1 (ru) |
RU (1) | RU2717641C2 (ru) |
Families Citing this family (121)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
WO2011041485A1 (en) | 2009-09-30 | 2011-04-07 | Gene Security Network, Inc. | Methods for non-invasive prenatal ploidy calling |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
EP2854057B1 (en) | 2010-05-18 | 2018-03-07 | Natera, Inc. | Methods for non-invasive pre-natal ploidy calling |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
AU2011348100B2 (en) | 2010-12-22 | 2016-08-25 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
RU2671980C2 (ru) | 2011-02-09 | 2018-11-08 | Натера, Инк. | Способы неинвазивного пренатального установления плоидности |
EP2697397B1 (en) | 2011-04-15 | 2017-04-05 | The Johns Hopkins University | Safe sequencing system |
US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
EP2946345B1 (en) | 2013-01-17 | 2024-04-03 | Personalis, Inc. | Methods and systems for genetic analysis |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US10262755B2 (en) | 2014-04-21 | 2019-04-16 | Natera, Inc. | Detecting cancer mutations and aneuploidy in chromosomal segments |
CN113774132A (zh) | 2014-04-21 | 2021-12-10 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
ES2741400T3 (es) | 2014-07-18 | 2020-02-10 | Univ Hong Kong Chinese | Análisis de patrones de metilación de tejidos en mezcla de ADN |
EP2977912A1 (de) * | 2014-07-25 | 2016-01-27 | Franz-Peter Dr. Liebel | Automatisierte Diagnostik |
KR20220127359A (ko) * | 2014-07-25 | 2022-09-19 | 유니버시티 오브 워싱톤 | 무세포 dna를 생성하는 조직 및/또는 세포 유형을 결정하는 방법 및 이를 사용하여 질환 또는 장애를 확인하는 방법 |
EP3212808B1 (en) | 2014-10-30 | 2022-03-02 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
WO2016183106A1 (en) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Methods and compositions for determining ploidy |
US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
US11302416B2 (en) * | 2015-09-02 | 2022-04-12 | Guardant Health | Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications |
EP3443066A4 (en) * | 2016-04-14 | 2019-12-11 | Guardant Health, Inc. | EARLY DETECTION METHODS FOR CANCER |
ES2913468T3 (es) * | 2016-04-15 | 2022-06-02 | Natera Inc | Métodos para la detección del cáncer de pulmón. |
US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
CA3126055A1 (en) | 2016-09-30 | 2018-04-05 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
GB201618485D0 (en) * | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
AU2017369018B2 (en) | 2016-11-30 | 2021-02-25 | The Chinese University Of Hong Kong | Analysis of cell-free DNA in urine and other samples |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
CN108277267B (zh) * | 2016-12-29 | 2019-08-13 | 安诺优达基因科技(北京)有限公司 | 检测基因突变的装置和用于对孕妇和胎儿的基因型进行分型的试剂盒 |
CN110199359B (zh) * | 2017-01-11 | 2023-07-14 | 皇家飞利浦有限公司 | 用于自动的包含或排除准则检测的方法和系统 |
WO2018156418A1 (en) | 2017-02-21 | 2018-08-30 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
US11342047B2 (en) * | 2017-04-21 | 2022-05-24 | Illumina, Inc. | Using cell-free DNA fragment size to detect tumor-associated variant |
CN108804876B (zh) * | 2017-05-05 | 2022-03-15 | 中国科学院上海药物研究所 | 用于计算癌症样本纯度和染色体倍性的方法和装置 |
KR102145417B1 (ko) * | 2017-05-24 | 2020-08-19 | 지니너스 주식회사 | 무세포 핵산으로부터 수득된 서열 분석 데이터에 대한 배경 대립인자의 빈도 분포를 생성하는 방법 및 이를 이용하여 무세포 핵산으로부터 변이를 검출하는 방법 |
CN109136355A (zh) * | 2017-06-19 | 2019-01-04 | 北京大学第三医院 | 一种体外评估胎儿双胎输血综合征发生的snp阵列芯片 |
WO2018237075A1 (en) | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | ASSESSING THE RISK OF GRAFT COMPLICATION WITH TOTAL ACELLULAR DNA |
US11450121B2 (en) * | 2017-06-27 | 2022-09-20 | The Regents Of The University Of California | Label-free digital brightfield analysis of nucleic acid amplification |
CN107164535A (zh) * | 2017-07-07 | 2017-09-15 | 沈阳宁沪科技有限公司 | 一种无创高通量甲基化结肠癌诊断、研究和治疗方法 |
US10622095B2 (en) * | 2017-07-21 | 2020-04-14 | Helix OpCo, LLC | Genomic services platform supporting multiple application providers |
US11608533B1 (en) * | 2017-08-21 | 2023-03-21 | The General Hospital Corporation | Compositions and methods for classifying tumors with microsatellite instability |
JP7029719B2 (ja) * | 2017-08-31 | 2022-03-04 | 静岡県 | バイオマーカー |
CN110021355B (zh) * | 2017-09-22 | 2021-05-04 | 深圳华大生命科学研究院 | 二倍体基因组测序片段的单倍体分型和变异检测方法和装置 |
EP3460071A1 (en) * | 2017-09-22 | 2019-03-27 | Lexogen GmbH | Estimating pre-pcr fragment numbers from post-pcr frequencies of unique molecular identifiers |
CN107641648A (zh) * | 2017-10-19 | 2018-01-30 | 深圳华大基因股份有限公司 | 一种用于检测染色体畸变的标准品及其制备方法 |
JP7299169B2 (ja) * | 2017-12-01 | 2023-06-27 | イルミナ インコーポレイテッド | 体細胞突然変異のクローン性を決定するための方法及びシステム |
CN109979529B (zh) * | 2017-12-28 | 2021-01-08 | 北京安诺优达医学检验实验室有限公司 | Cnv检测装置 |
US20210158895A1 (en) * | 2018-04-13 | 2021-05-27 | Dana-Farber Cancer Institute, Inc. | Ultra-sensitive detection of cancer by algorithmic analysis |
US11874220B2 (en) | 2018-04-26 | 2024-01-16 | Ppg Industries Ohio, Inc. | Formulation systems and methods employing target coating data results |
US10970879B2 (en) | 2018-04-26 | 2021-04-06 | Ppg Industries Ohio, Inc. | Formulation systems and methods employing target coating data results |
US10871888B2 (en) | 2018-04-26 | 2020-12-22 | Ppg Industries Ohio, Inc. | Systems, methods, and interfaces for rapid coating generation |
US11119035B2 (en) * | 2018-04-26 | 2021-09-14 | Ppg Industries Ohio, Inc. | Systems and methods for rapid coating composition determinations |
CN108588201B (zh) * | 2018-05-11 | 2019-08-09 | 浙江省人民医院 | 一种结直肠癌西妥昔单抗耐药性痕量dna突变检测的方法及装置 |
US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
TW202410055A (zh) | 2018-06-01 | 2024-03-01 | 美商格瑞爾有限責任公司 | 用於資料分類之卷積神經網路系統及方法 |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
CN109461473B (zh) * | 2018-09-30 | 2019-12-17 | 北京优迅医疗器械有限公司 | 胎儿游离dna浓度获取方法和装置 |
CN109971846A (zh) * | 2018-11-29 | 2019-07-05 | 时代基因检测中心有限公司 | 使用双等位基因snp靶向下一代测序的非侵入性产前测定非整倍体的方法 |
US11581062B2 (en) | 2018-12-10 | 2023-02-14 | Grail, Llc | Systems and methods for classifying patients with respect to multiple cancer classes |
CN109686401B (zh) * | 2018-12-19 | 2022-08-05 | 上海蓝沙生物科技有限公司 | 一种识别异源低频基因组信号唯一性的方法及其应用 |
CN109801677B (zh) * | 2018-12-29 | 2023-05-23 | 浙江安诺优达生物科技有限公司 | 测序数据自动化分析方法、装置和电子设备 |
EP3915118A1 (en) * | 2019-01-25 | 2021-12-01 | Pacific Biosciences Of California, Inc. | Systems and methods for graph based mapping of nucleic acid fragments |
CN109837344B (zh) * | 2019-03-04 | 2022-12-27 | 天津医科大学 | 一种甲基化的EphA7核苷酸片段及其检测方法和应用 |
WO2020206290A1 (en) * | 2019-04-03 | 2020-10-08 | The Medical College Of Wisconsin, Inc. | Methods for assessing risk using total cell-free dna |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
CN110129439A (zh) * | 2019-04-28 | 2019-08-16 | 安徽鼎晶生物科技有限公司 | 一种人brca1/2基因变异检测质控品及其制备方法和应用 |
CN110106063B (zh) * | 2019-05-06 | 2022-07-08 | 臻和精准医学检验实验室无锡有限公司 | 基于二代测序的用于神经胶质瘤1p/19q联合缺失检测的系统 |
AU2020274348A1 (en) * | 2019-05-13 | 2021-12-09 | Grail, Llc | Model-based featurization and classification |
US20210366569A1 (en) * | 2019-06-03 | 2021-11-25 | Illumina, Inc. | Limit of detection based quality control metric |
CN110379465A (zh) * | 2019-07-19 | 2019-10-25 | 元码基因科技(北京)股份有限公司 | 基于rna靶向测序和机器学习的癌症组织溯源方法 |
CN110452988A (zh) * | 2019-08-27 | 2019-11-15 | 武汉友芝友医疗科技股份有限公司 | 检测esr1基因突变的引物组、试剂、试剂盒和方法 |
CN110648722B (zh) * | 2019-09-19 | 2022-05-31 | 首都医科大学附属北京儿童医院 | 新生儿遗传病患病风险评估的装置 |
CN112634986A (zh) * | 2019-09-24 | 2021-04-09 | 厦门希吉亚生物科技有限公司 | 一种基于孕妇外周血对双胞胎合子性质的无创鉴定方法 |
DE112020005433T5 (de) | 2019-11-06 | 2022-10-06 | The Board Of Trustees Of The Leland Stanford Junior University | Verfahren und Systeme zur Analyse von Nukleinsäuremolekülen |
US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
CN113496769B (zh) * | 2020-03-20 | 2023-11-07 | 梅傲科技(广州)有限公司 | 基于病理组织的三联综合肿瘤分析系统和应用 |
CN111370065B (zh) * | 2020-03-26 | 2022-10-04 | 北京吉因加医学检验实验室有限公司 | 一种检测rna跨样本交叉污染率的方法和装置 |
CN112885406B (zh) * | 2020-04-16 | 2023-01-31 | 深圳裕策生物科技有限公司 | 检测hla杂合性缺失的方法及系统 |
US20210326332A1 (en) * | 2020-04-17 | 2021-10-21 | International Business Machines Corporation | Temporal directed cycle detection and pruning in transaction graphs |
CN111724860B (zh) * | 2020-06-18 | 2021-03-16 | 深圳吉因加医学检验实验室 | 一种基于测序数据识别染色质开放区域的方法及装置 |
US11675599B2 (en) * | 2020-08-04 | 2023-06-13 | Dell Products L.P. | Systems and methods for managing system rollup of accelerator health |
CN114277129A (zh) * | 2020-09-28 | 2022-04-05 | 北京市神经外科研究所 | 一种swi/snf基因改变在辅助诊断和预后脊索瘤中的应用 |
CN112094911A (zh) * | 2020-10-10 | 2020-12-18 | 广西医科大学 | Nrk在肺癌治疗和预后诊断中的医药用途 |
CN112397144B (zh) * | 2020-10-29 | 2021-06-15 | 无锡臻和生物科技股份有限公司 | 检测基因突变及表达量的方法及装置 |
JP2023548113A (ja) * | 2020-10-30 | 2023-11-15 | マイオーム,インコーポレイテッド | Cnv検出を改善するための非誤り伝播相決定技術ならびに対立遺伝子バランスの組み合わせの使用 |
US11354286B1 (en) * | 2020-11-02 | 2022-06-07 | Workday, Inc. | Outlier identification and removal |
CN112634991B (zh) * | 2020-12-18 | 2022-07-19 | 长沙都正生物科技股份有限公司 | 基因分型方法、装置、电子设备及存储介质 |
CN112592976B (zh) * | 2020-12-30 | 2021-09-21 | 深圳市海普洛斯生物科技有限公司 | 一种检测met基因扩增的方法及装置 |
WO2022190752A1 (ja) | 2021-03-12 | 2022-09-15 | 富士フイルム株式会社 | がん検査試薬セット、がん検査試薬セットの製造方法及びがん検査方法 |
CN113096736B (zh) * | 2021-03-26 | 2023-10-31 | 北京源生康泰基因科技有限公司 | 一种基于纳米孔测序的病毒实时自动分析方法及系统 |
WO2022212590A1 (en) * | 2021-03-31 | 2022-10-06 | Predicine, Inc. | Systems and methods for multi-analyte detection of cancer |
US11783912B2 (en) | 2021-05-05 | 2023-10-10 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and systems for analyzing nucleic acid molecules |
CN113637751A (zh) * | 2021-07-16 | 2021-11-12 | 暨南大学 | Tnfaip3非编码序列突变检测试剂在制备预测t细胞淋巴瘤预后试剂盒中的应用 |
CN113808660B (zh) * | 2021-09-13 | 2024-02-13 | 复旦大学附属华山医院 | 基于自然选择及数据库的遗传性罕见病患病率贝叶斯计算模型及其构建方法和应用 |
WO2023060236A1 (en) * | 2021-10-08 | 2023-04-13 | Foundation Medicine, Inc. | Methods and systems for automated calling of copy number alterations |
WO2023081639A1 (en) * | 2021-11-03 | 2023-05-11 | Foundation Medicine, Inc. | System and method for identifying copy number alterations |
EP4184514A1 (en) * | 2021-11-23 | 2023-05-24 | Eone Reference Laboratory | Apparatus and method for diagnosing cancer using liquid biopsy data |
CN114093417B (zh) * | 2021-11-23 | 2022-10-04 | 深圳吉因加信息科技有限公司 | 一种鉴定染色体臂杂合性缺失的方法和装置 |
CN113913525A (zh) * | 2021-11-24 | 2022-01-11 | 广州医科大学 | Dnase1l3基因作为肝癌侵袭转移的检测和/或防治靶点的应用 |
US11788152B2 (en) | 2022-01-28 | 2023-10-17 | Flagship Pioneering Innovations Vi, Llc | Multiple-tiered screening and second analysis |
US20240150840A1 (en) * | 2022-02-22 | 2024-05-09 | Flagship Pioneering Innovations Vi, Llc | Intra-individual analysis for presence of health conditions |
WO2023177901A1 (en) * | 2022-03-17 | 2023-09-21 | Delfi Diagnostics, Inc. | Method of monitoring cancer using fragmentation profiles |
CN114807377B (zh) * | 2022-06-29 | 2022-09-23 | 南京世和基因生物技术股份有限公司 | 膀胱癌预后生存期标志物的应用、评估装置以及计算机可读取介质 |
CN116805510A (zh) * | 2022-09-01 | 2023-09-26 | 杭州链康医学检验实验室有限公司 | 用于判断样本配对或污染的位点组合及其应用 |
CN116004800B (zh) * | 2022-12-09 | 2023-09-05 | 中国农业科学院北京畜牧兽医研究所 | 一种cnv标记在绵羊肥瘦尾早期筛选中的应用 |
CN117334249A (zh) * | 2023-05-30 | 2024-01-02 | 上海品峰医疗科技有限公司 | 基于扩增子测序数据检测拷贝数变异的方法、设备和介质 |
CN117551782B (zh) * | 2023-11-24 | 2024-05-07 | 江苏省家禽科学研究所 | 与鸡蛋尖端蛋壳厚度相关的分子标记在鸡遗传育种中的应用 |
Family Cites Families (548)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3957654A (en) | 1974-02-27 | 1976-05-18 | Becton, Dickinson And Company | Plasma separator with barrier to eject sealant |
US4040785A (en) | 1976-10-18 | 1977-08-09 | Technicon Instruments Corporation | Lysable blood preservative composition |
US5242794A (en) | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4935342A (en) | 1986-12-01 | 1990-06-19 | Syngene, Inc. | Method of isolating and purifying nucleic acids from biological samples |
US4942124A (en) | 1987-08-11 | 1990-07-17 | President And Fellows Of Harvard College | Multiplex sequencing |
JP3040121B2 (ja) | 1988-01-12 | 2000-05-08 | ジェネンテク,インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
US5153117A (en) | 1990-03-27 | 1992-10-06 | Genetype A.G. | Fetal cell recovery method |
US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
US5262329A (en) | 1991-06-13 | 1993-11-16 | Carver Jr Edward L | Method for improved multiple species blood analysis |
IL103935A0 (en) | 1991-12-04 | 1993-05-13 | Du Pont | Method for the identification of microorganisms by the utilization of directed and arbitrary dna amplification |
US5965362A (en) | 1992-03-04 | 1999-10-12 | The Regents Of The University Of California | Comparative genomic hybridization (CGH) |
GB9305984D0 (en) | 1993-03-23 | 1993-05-12 | Royal Free Hosp School Med | Predictive assay |
BR9407003A (pt) | 1993-07-05 | 1996-03-26 | North Gen Hospital Nhs Trust | Preparaçao e estabilizaçao de células |
WO1995006137A1 (en) | 1993-08-27 | 1995-03-02 | Australian Red Cross Society | Detection of genes |
CH686982A5 (fr) | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
SE9400522D0 (sv) | 1994-02-16 | 1994-02-16 | Ulf Landegren | Method and reagent for detecting specific nucleotide sequences |
US5716776A (en) | 1994-03-04 | 1998-02-10 | Mark H. Bogart | Enrichment by preferential mitosis of fetal lymphocytes from a maternal blood sample |
US5891734A (en) | 1994-08-01 | 1999-04-06 | Abbott Laboratories | Method for performing automated analysis |
US6025128A (en) | 1994-09-29 | 2000-02-15 | The University Of Tulsa | Prediction of prostate cancer progression by analysis of selected predictive parameters |
US6479235B1 (en) | 1994-09-30 | 2002-11-12 | Promega Corporation | Multiplex amplification of short tandem repeat loci |
US5648220A (en) | 1995-02-14 | 1997-07-15 | New England Medical Center Hospitals, Inc. | Methods for labeling intracytoplasmic molecules |
WO1996036736A2 (en) | 1995-05-19 | 1996-11-21 | Abbott Laboratories | Wide dynamic range nucleic acid detection using an aggregate primer series |
US6720140B1 (en) | 1995-06-07 | 2004-04-13 | Invitrogen Corporation | Recombinational cloning using engineered recombination sites |
US5733729A (en) | 1995-09-14 | 1998-03-31 | Affymetrix, Inc. | Computer-aided probability base calling for arrays of nucleic acid probes on chips |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
US5736033A (en) | 1995-12-13 | 1998-04-07 | Coleman; Charles M. | Separator float for blood collection tubes with water swellable material |
US6852487B1 (en) | 1996-02-09 | 2005-02-08 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
EP0929694A4 (en) | 1996-03-15 | 2002-05-02 | Penn State Res Found | DETECTION OF TUMOR-RELATED EXTRACELLULAR NUCLEIC ACID USING PLASMA OR BLOOD SERUM USING NUCLEIC ACID AMPLIFICATION TESTS |
CA2250118C (en) | 1996-03-26 | 2009-09-29 | Michael S. Kopreski | Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
US6108635A (en) | 1996-05-22 | 2000-08-22 | Interleukin Genetics, Inc. | Integrated disease information system |
US6100029A (en) | 1996-08-14 | 2000-08-08 | Exact Laboratories, Inc. | Methods for the detection of chromosomal aberrations |
US6300077B1 (en) | 1996-08-14 | 2001-10-09 | Exact Sciences Corporation | Methods for the detection of nucleic acids |
US6221654B1 (en) | 1996-09-25 | 2001-04-24 | California Institute Of Technology | Method and apparatus for analysis and sorting of polynucleotides based on size |
US5860917A (en) | 1997-01-15 | 1999-01-19 | Chiron Corporation | Method and apparatus for predicting therapeutic outcomes |
US5824467A (en) | 1997-02-25 | 1998-10-20 | Celtrix Pharmaceuticals | Methods for predicting drug response |
GB9704444D0 (en) | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
US20010051341A1 (en) | 1997-03-04 | 2001-12-13 | Isis Innovation Limited | Non-invasive prenatal diagnosis |
ES2230631T3 (es) | 1997-03-20 | 2005-05-01 | F. Hoffmann-La Roche Ag | Cebadores modificados. |
EP2327797B1 (en) | 1997-04-01 | 2015-11-25 | Illumina Cambridge Limited | Method of nucleic acid sequencing |
US6143496A (en) | 1997-04-17 | 2000-11-07 | Cytonix Corporation | Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly |
US20020119478A1 (en) | 1997-05-30 | 2002-08-29 | Diagen Corporation | Methods for detection of nucleic acid sequences in urine |
US5994148A (en) | 1997-06-23 | 1999-11-30 | The Regents Of University Of California | Method of predicting and enhancing success of IVF/ET pregnancy |
US6833242B2 (en) | 1997-09-23 | 2004-12-21 | California Institute Of Technology | Methods for detecting and sorting polynucleotides based on size |
US6124120A (en) | 1997-10-08 | 2000-09-26 | Yale University | Multiple displacement amplification |
AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
US6406671B1 (en) | 1998-12-05 | 2002-06-18 | Becton, Dickinson And Company | Device and method for separating components of a fluid sample |
EP1177281B1 (en) | 1999-04-30 | 2009-01-21 | Cyclops Genome Sciences Limited | Isolation of nucleic acid |
US6180349B1 (en) | 1999-05-18 | 2001-01-30 | The Regents Of The University Of California | Quantitative PCR method to enumerate DNA copy number |
US7058517B1 (en) | 1999-06-25 | 2006-06-06 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
US6964847B1 (en) | 1999-07-14 | 2005-11-15 | Packard Biosciences Company | Derivative nucleic acids and uses thereof |
GB9917307D0 (en) | 1999-07-23 | 1999-09-22 | Sec Dep Of The Home Department | Improvements in and relating to analysis of DNA |
EP1196623B8 (en) | 1999-07-23 | 2008-05-21 | Forensic Science Service Ltd | Method for detecting single nucleotide polymorphisms |
US6440706B1 (en) | 1999-08-02 | 2002-08-27 | Johns Hopkins University | Digital amplification |
US6251604B1 (en) | 1999-08-13 | 2001-06-26 | Genopsys, Inc. | Random mutagenesis and amplification of nucleic acid |
WO2001034844A1 (en) | 1999-11-10 | 2001-05-17 | Ligochem, Inc. | Method for isolating dna from a proteinaceous medium and kit for performing method |
US6221603B1 (en) | 2000-02-04 | 2001-04-24 | Molecular Dynamics, Inc. | Rolling circle amplification assay for nucleic acid analysis |
ATE492652T1 (de) | 2000-02-07 | 2011-01-15 | Illumina Inc | Nukleinsäuredetektionsverfahren mit universellem priming |
US7955794B2 (en) | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7510834B2 (en) | 2000-04-13 | 2009-03-31 | Hidetoshi Inoko | Gene mapping method using microsatellite genetic polymorphism markers |
GB0009179D0 (en) | 2000-04-13 | 2000-05-31 | Imp College Innovations Ltd | Non-invasive prenatal diagnosis |
US6828098B2 (en) | 2000-05-20 | 2004-12-07 | The Regents Of The University Of Michigan | Method of producing a DNA library using positional amplification based on the use of adaptors and nick translation |
CA2409774A1 (en) | 2000-05-23 | 2001-11-29 | Variagenics, Inc. | Methods for genetic analysis of dna to detect sequence variances |
US20030009295A1 (en) | 2001-03-14 | 2003-01-09 | Victor Markowitz | System and method for retrieving and using gene expression data from multiple sources |
US6605451B1 (en) | 2000-06-06 | 2003-08-12 | Xtrana, Inc. | Methods and devices for multiplexing amplification reactions |
US7087414B2 (en) | 2000-06-06 | 2006-08-08 | Applera Corporation | Methods and devices for multiplexing amplification reactions |
JP2004500867A (ja) | 2000-06-07 | 2004-01-15 | ベイラー カレッジ オブ メディシン | アレイ利用型核酸ハイブリダイゼーションのための新規な組成物および方法 |
US7058616B1 (en) | 2000-06-08 | 2006-06-06 | Virco Bvba | Method and system for predicting resistance of a disease to a therapeutic agent using a neural network |
GB0016742D0 (en) | 2000-07-10 | 2000-08-30 | Simeg Limited | Diagnostic method |
AU2002246612B2 (en) | 2000-10-24 | 2007-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Direct multiplex characterization of genomic DNA |
US20020107640A1 (en) | 2000-11-14 | 2002-08-08 | Ideker Trey E. | Methods for determining the true signal of an analyte |
WO2002055985A2 (en) | 2000-11-15 | 2002-07-18 | Roche Diagnostics Corp | Methods and reagents for identifying rare fetal cells in the material circulation |
WO2002044411A1 (en) | 2000-12-01 | 2002-06-06 | Rosetta Inpharmatics, Inc. | Use of profiling for detecting aneuploidy |
US7218764B2 (en) | 2000-12-04 | 2007-05-15 | Cytokinetics, Inc. | Ploidy classification method |
AR031640A1 (es) | 2000-12-08 | 2003-09-24 | Applied Research Systems | Amplificacion isotermica de acidos nucleicos en un soporte solido |
JP2002300894A (ja) | 2001-02-01 | 2002-10-15 | Inst Of Physical & Chemical Res | 一塩基多型タイピング方法 |
US20020182622A1 (en) | 2001-02-01 | 2002-12-05 | Yusuke Nakamura | Method for SNP (single nucleotide polymorphism) typing |
WO2002070751A1 (en) | 2001-03-02 | 2002-09-12 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Pcr method |
AU2002238994A1 (en) | 2001-03-23 | 2002-10-08 | Center For Advanced Science And Technology Incubation, Ltd. | Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody |
US6489135B1 (en) | 2001-04-17 | 2002-12-03 | Atairgintechnologies, Inc. | Determination of biological characteristics of embryos fertilized in vitro by assaying for bioactive lipids in culture media |
FR2824144B1 (fr) | 2001-04-30 | 2004-09-17 | Metagenex S A R L | Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel |
US7392199B2 (en) | 2001-05-01 | 2008-06-24 | Quest Diagnostics Investments Incorporated | Diagnosing inapparent diseases from common clinical tests using Bayesian analysis |
US7262030B2 (en) | 2001-05-09 | 2007-08-28 | Virginia Commonwealth University | Multiple sequencible and ligatible structures for genomic analysis |
US20040126760A1 (en) | 2001-05-17 | 2004-07-01 | Natalia Broude | Novel compositions and methods for carrying out multple pcr reactions on a single sample |
US7026121B1 (en) | 2001-06-08 | 2006-04-11 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
EP1397512A2 (en) | 2001-06-22 | 2004-03-17 | University of Geneva | Method for detecting diseases caused by chromosomal imbalances |
US20030101000A1 (en) | 2001-07-24 | 2003-05-29 | Bader Joel S. | Family based tests of association using pooled DNA and SNP markers |
AU2002327308A1 (en) | 2001-07-25 | 2003-02-17 | Oncomedx Inc. | Methods for evaluating pathologic conditions using extracellular rna |
US7297778B2 (en) | 2001-07-25 | 2007-11-20 | Affymetrix, Inc. | Complexity management of genomic DNA |
US6958211B2 (en) | 2001-08-08 | 2005-10-25 | Tibotech Bvba | Methods of assessing HIV integrase inhibitor therapy |
JP2005501236A (ja) | 2001-08-23 | 2005-01-13 | イムニベスト・コーポレイション | 分析用の細胞および生物学的検体の安定化 |
US6807491B2 (en) | 2001-08-30 | 2004-10-19 | Hewlett-Packard Development Company, L.P. | Method and apparatus for combining gene predictions using bayesian networks |
US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
AUPR749901A0 (en) | 2001-09-06 | 2001-09-27 | Monash University | Method of identifying chromosomal abnormalities and prenatal diagnosis |
US7153656B2 (en) | 2001-09-11 | 2006-12-26 | Los Alamos National Security, Llc | Nucleic acid sequence detection using multiplexed oligonucleotide PCR |
US8986944B2 (en) | 2001-10-11 | 2015-03-24 | Aviva Biosciences Corporation | Methods and compositions for separating rare cells from fluid samples |
US20040014067A1 (en) | 2001-10-12 | 2004-01-22 | Third Wave Technologies, Inc. | Amplification methods and compositions |
EP1442139A4 (en) | 2001-10-12 | 2005-01-26 | Univ Queensland | SELECTION AND AMPLIFICATION OF MULTIPLE GENETIC MARKERS |
US6617137B2 (en) | 2001-10-15 | 2003-09-09 | Molecular Staging Inc. | Method of amplifying whole genomes without subjecting the genome to denaturing conditions |
US7297485B2 (en) | 2001-10-15 | 2007-11-20 | Qiagen Gmbh | Method for nucleic acid amplification that results in low amplification bias |
US7511704B2 (en) | 2001-11-20 | 2009-03-31 | Illinois Tool Works Inc. | Acoustic wave touch bar system and method of use |
US20030119004A1 (en) | 2001-12-05 | 2003-06-26 | Wenz H. Michael | Methods for quantitating nucleic acids using coupled ligation and amplification |
JP4229237B2 (ja) | 2001-12-11 | 2009-02-25 | 株式会社ネーテック | 血液細胞分離システム |
US7198897B2 (en) | 2001-12-19 | 2007-04-03 | Brandeis University | Late-PCR |
ES2274861T3 (es) | 2001-12-24 | 2007-06-01 | Wolfgang Prof. Holzgreve | Metodo para el diagnostico no-invasivo de transplantes y transfusiones. |
US20040115629A1 (en) | 2002-01-09 | 2004-06-17 | Panzer Scott R | Molecules for diagnostics and therapeutics |
US20030211522A1 (en) | 2002-01-18 | 2003-11-13 | Landes Gregory M. | Methods for fetal DNA detection and allele quantitation |
US7035739B2 (en) | 2002-02-01 | 2006-04-25 | Rosetta Inpharmatics Llc | Computer systems and methods for identifying genes and determining pathways associated with traits |
MXPA04008477A (es) | 2002-03-01 | 2005-10-26 | Ravgen Inc | Metodos para deteccion de trastornos geneticos. |
US6977162B2 (en) | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
US20060229823A1 (en) | 2002-03-28 | 2006-10-12 | Affymetrix, Inc. | Methods and computer software products for analyzing genotyping data |
US7211191B2 (en) | 2004-09-30 | 2007-05-01 | Thermogenesis Corp. | Blood component separation method and apparatus |
US7241281B2 (en) | 2002-04-08 | 2007-07-10 | Thermogenesis Corporation | Blood component separation method and apparatus |
US20030235848A1 (en) | 2002-04-11 | 2003-12-25 | Matt Neville | Characterization of CYP 2D6 alleles |
US20040096874A1 (en) | 2002-04-11 | 2004-05-20 | Third Wave Technologies, Inc. | Characterization of CYP 2D6 genotypes |
AU2003231244A1 (en) | 2002-05-02 | 2003-11-17 | University Of North Carolina At Chapel Hill | In vitro mutagenesis, phenotyping, and gene mapping |
US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
US20070178478A1 (en) | 2002-05-08 | 2007-08-02 | Dhallan Ravinder S | Methods for detection of genetic disorders |
US7442506B2 (en) | 2002-05-08 | 2008-10-28 | Ravgen, Inc. | Methods for detection of genetic disorders |
US20040009518A1 (en) | 2002-05-14 | 2004-01-15 | The Chinese University Of Hong Kong | Methods for evaluating a disease condition by nucleic acid detection and fractionation |
US20040229231A1 (en) | 2002-05-28 | 2004-11-18 | Frudakis Tony N. | Compositions and methods for inferring ancestry |
WO2003102595A1 (en) | 2002-05-31 | 2003-12-11 | Genetype Pty Ltd | Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood |
AU2003243475A1 (en) | 2002-06-13 | 2003-12-31 | New York University | Early noninvasive prenatal test for aneuploidies and heritable conditions |
US7108976B2 (en) | 2002-06-17 | 2006-09-19 | Affymetrix, Inc. | Complexity management of genomic DNA by locus specific amplification |
US7097976B2 (en) | 2002-06-17 | 2006-08-29 | Affymetrix, Inc. | Methods of analysis of allelic imbalance |
US20050009069A1 (en) | 2002-06-25 | 2005-01-13 | Affymetrix, Inc. | Computer software products for analyzing genotyping |
AU2003247715B8 (en) | 2002-06-28 | 2008-06-05 | Orchid Cellmark Inc. | Methods and compositions for analyzing compromised samples using single nucleotide polymorphism panels |
EP1388812A1 (en) | 2002-07-04 | 2004-02-11 | Ronald E. Dr. Kates | Method for training a learning-capable system |
US20040117346A1 (en) | 2002-09-20 | 2004-06-17 | Kilian Stoffel | Computer-based method and apparatus for repurposing an ontology |
US7459273B2 (en) | 2002-10-04 | 2008-12-02 | Affymetrix, Inc. | Methods for genotyping selected polymorphism |
AU2003285861A1 (en) | 2002-10-07 | 2004-05-04 | University Of Medicine And Dentistry Of New Jersey | High throughput multiplex dna sequence amplifications |
US10229244B2 (en) | 2002-11-11 | 2019-03-12 | Affymetrix, Inc. | Methods for identifying DNA copy number changes using hidden markov model based estimations |
US7424368B2 (en) | 2002-11-11 | 2008-09-09 | Affymetix, Inc. | Methods for identifying DNA copy number changes |
JP2006508662A (ja) | 2002-12-04 | 2006-03-16 | アプレラ コーポレイション | ポリヌクレオチドの多重増幅 |
PT2469077T (pt) | 2003-01-02 | 2020-07-10 | Wobben Properties Gmbh | Sistema de energia eólica com uma pá de rotor |
WO2004065617A2 (en) | 2003-01-17 | 2004-08-05 | The Trustees Of Boston University | Haplotype analysis |
WO2004065628A1 (en) | 2003-01-21 | 2004-08-05 | Guoliang Fu | Quantitative multiplex detection of nucleic acids |
US7575865B2 (en) | 2003-01-29 | 2009-08-18 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
JP4480715B2 (ja) | 2003-01-29 | 2010-06-16 | 454 コーポレーション | 二重末端シーケンシング |
AU2004217872B2 (en) | 2003-03-05 | 2010-03-25 | Genetic Technologies Limited | Identification of fetal DNA and fetal cell markers in maternal plasma or serum |
US20040209299A1 (en) | 2003-03-07 | 2004-10-21 | Rubicon Genomics, Inc. | In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA |
US20040197832A1 (en) | 2003-04-03 | 2004-10-07 | Mor Research Applications Ltd. | Non-invasive prenatal genetic diagnosis using transcervical cells |
WO2004099439A1 (en) | 2003-05-09 | 2004-11-18 | Tsinghua University | Methods and compositions for optimizing multiplex pcr primers |
US20050144664A1 (en) | 2003-05-28 | 2005-06-30 | Pioneer Hi-Bred International, Inc. | Plant breeding method |
US20040259100A1 (en) | 2003-06-20 | 2004-12-23 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
DE602004019941D1 (de) | 2003-07-31 | 2009-04-23 | Sequenom Inc | Verfahren für multiplex-polymerasekettenreaktionen auf hohem niveau und homogenen massenverlängerungsreaktionen zur genotypisierung von polymorphismen |
US8346482B2 (en) | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
WO2005021793A1 (en) | 2003-08-29 | 2005-03-10 | Pantarhei Bioscience B.V. | Prenatal diagnosis of down syndrome by detection of fetal rna markers in maternal blood |
WO2005023091A2 (en) | 2003-09-05 | 2005-03-17 | The Trustees Of Boston University | Method for non-invasive prenatal diagnosis |
US20050053950A1 (en) | 2003-09-08 | 2005-03-10 | Enrique Zudaire Ubani | Protocol and software for multiplex real-time PCR quantification based on the different melting temperatures of amplicons |
JPWO2005028645A1 (ja) | 2003-09-24 | 2007-11-15 | 株式会社産学連携機構九州 | MDR1遺伝子の5’制御領域におけるSNPs |
WO2005030999A1 (en) | 2003-09-25 | 2005-04-07 | Dana-Farber Cancer Institute, Inc | Methods to detect lineage-specific cells |
EP1689884A4 (en) | 2003-10-08 | 2007-04-04 | Univ Boston | METHODS OF PRENATAL DIAGNOSIS OF CHROMOSOMIC ANOMALIES |
CA2482097C (en) | 2003-10-13 | 2012-02-21 | F. Hoffmann-La Roche Ag | Methods for isolating nucleic acids |
ATE435301T1 (de) | 2003-10-16 | 2009-07-15 | Sequenom Inc | Nicht invasiver nachweis fötaler genetischer merkmale |
WO2005039389A2 (en) | 2003-10-22 | 2005-05-06 | 454 Corporation | Sequence-based karyotyping |
EP1678329A4 (en) | 2003-10-30 | 2008-07-02 | Tufts New England Medical Ct | PRENATAL DIAGNOSIS USING CELL-FREE FEDERAL DNA IN FRUIT WATER |
US20050164252A1 (en) | 2003-12-04 | 2005-07-28 | Yeung Wah Hin A. | Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell |
EP1706488B1 (en) | 2004-01-12 | 2013-07-24 | Roche NimbleGen, Inc. | Method of performing pcr amplification on a microarray |
US20100216151A1 (en) | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
US20100216153A1 (en) | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
US20060046258A1 (en) | 2004-02-27 | 2006-03-02 | Lapidus Stanley N | Applications of single molecule sequencing |
US7035740B2 (en) | 2004-03-24 | 2006-04-25 | Illumina, Inc. | Artificial intelligence and global normalization methods for genotyping |
JP4437050B2 (ja) | 2004-03-26 | 2010-03-24 | 株式会社日立製作所 | 診断支援システム、診断支援方法および診断支援サービスの提供方法 |
US7805282B2 (en) | 2004-03-30 | 2010-09-28 | New York University | Process, software arrangement and computer-accessible medium for obtaining information associated with a haplotype |
ATE450549T1 (de) | 2004-03-31 | 2009-12-15 | Adnagen Ag | Monoklonale antikörper mit spezifität für fetale erythroidzellen |
US7414118B1 (en) | 2004-04-14 | 2008-08-19 | Applied Biosystems Inc. | Modified oligonucleotides and applications thereof |
US7468249B2 (en) | 2004-05-05 | 2008-12-23 | Biocept, Inc. | Detection of chromosomal disorders |
US7709194B2 (en) | 2004-06-04 | 2010-05-04 | The Chinese University Of Hong Kong | Marker for prenatal diagnosis and monitoring |
KR20070034588A (ko) | 2004-06-14 | 2007-03-28 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | Cd34+/cd36+ 태아 세포에는 결합하지만 성체세포에는 결합하지 않는 항체 |
WO2006002491A1 (en) | 2004-07-06 | 2006-01-12 | Genera Biosystems Pty Ltd | Method of detecting aneuploidy |
DE102004036285A1 (de) | 2004-07-27 | 2006-02-16 | Advalytix Ag | Verfahren zum Bestimmen der Häufigkeit von Sequenzen einer Probe |
WO2006020617A1 (en) | 2004-08-09 | 2006-02-23 | Generation Biotech, Llc | Method for nucleic acid isolation and amplification |
CA2577741A1 (en) | 2004-08-18 | 2006-03-02 | Abbott Molecular, Inc. | Determining data quality and/or segmental aneusomy using a computer system |
US7634808B1 (en) | 2004-08-20 | 2009-12-15 | Symantec Corporation | Method and apparatus to block fast-spreading computer worms that use DNS MX record queries |
JP4810164B2 (ja) | 2004-09-03 | 2011-11-09 | 富士フイルム株式会社 | 核酸分離精製方法 |
US8024128B2 (en) | 2004-09-07 | 2011-09-20 | Gene Security Network, Inc. | System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data |
US20060088574A1 (en) | 2004-10-25 | 2006-04-27 | Manning Paul B | Nutritional supplements |
US20060134662A1 (en) | 2004-10-25 | 2006-06-22 | Pratt Mark R | Method and system for genotyping samples in a normalized allelic space |
US9109256B2 (en) * | 2004-10-27 | 2015-08-18 | Esoterix Genetic Laboratories, Llc | Method for monitoring disease progression or recurrence |
WO2006055761A1 (en) | 2004-11-17 | 2006-05-26 | Mosaic Reproductive Health And Genetics, Llc | Methods of determining human egg competency |
US8389578B2 (en) | 2004-11-24 | 2013-03-05 | Adamas Pharmaceuticals, Inc | Composition and method for treating neurological disease |
US20070042384A1 (en) | 2004-12-01 | 2007-02-22 | Weiwei Li | Method for isolating and modifying DNA from blood and body fluids |
WO2006091979A2 (en) | 2005-02-25 | 2006-08-31 | The Regents Of The University Of California | Full karyotype single cell chromosome analysis |
US7618777B2 (en) | 2005-03-16 | 2009-11-17 | Agilent Technologies, Inc. | Composition and method for array hybridization |
JP5629051B2 (ja) | 2005-03-18 | 2014-11-19 | ザ チャイニーズ ユニバーシティー オブ ホンコンThe Chinese University Of Hongkong | 出生前診断およびモニタリングのためのマーカー |
CN101137760B (zh) | 2005-03-18 | 2011-01-26 | 香港中文大学 | 检测染色体非整倍性的方法 |
US20060228721A1 (en) | 2005-04-12 | 2006-10-12 | Leamon John H | Methods for determining sequence variants using ultra-deep sequencing |
ES2404311T3 (es) | 2005-04-12 | 2013-05-27 | 454 Life Sciences Corporation | Métodos para determinar variantes de secuencias usando secuenciación ultraprofunda |
JP2008545418A (ja) | 2005-05-27 | 2008-12-18 | ジョン ウェイン キャンサー インスティチュート | 癌の診断、予後診断、および治療のための遊離循環dnaの使用 |
JP4879975B2 (ja) | 2005-05-31 | 2012-02-22 | アプライド バイオシステムズ リミテッド ライアビリティー カンパニー | 短い核酸のマルチプレックス増幅 |
US7601499B2 (en) | 2005-06-06 | 2009-10-13 | 454 Life Sciences Corporation | Paired end sequencing |
DK1907583T4 (da) | 2005-06-15 | 2020-01-27 | Complete Genomics Inc | Enkeltmolekyle-arrays til genetisk og kemisk analyse |
ATE489473T1 (de) | 2005-07-15 | 2010-12-15 | Life Technologies Corp | Analyse von boten-rna und mikro-rna im gleichen reaktionsansatz |
US20070020640A1 (en) | 2005-07-21 | 2007-01-25 | Mccloskey Megan L | Molecular encoding of nucleic acid templates for PCR and other forms of sequence analysis |
RU2290078C1 (ru) * | 2005-07-25 | 2006-12-27 | Евгений Владимирович Новичков | Способ прогнозирования рецидива серозного рака яичников |
US10081839B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc | System and method for cleaning noisy genetic data and determining chromosome copy number |
US20070027636A1 (en) | 2005-07-29 | 2007-02-01 | Matthew Rabinowitz | System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions |
US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US10083273B2 (en) | 2005-07-29 | 2018-09-25 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US8532930B2 (en) | 2005-11-26 | 2013-09-10 | Natera, Inc. | Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals |
US8515679B2 (en) | 2005-12-06 | 2013-08-20 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
US20070178501A1 (en) | 2005-12-06 | 2007-08-02 | Matthew Rabinowitz | System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology |
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
DK1924704T3 (da) | 2005-08-02 | 2011-09-05 | Rubicon Genomics Inc | Sammensætninger og fremgangsmåder til bearbejdning og mangfoldiggørelse af DNA, herunder ved anvendelse af flere enzymer i en enkelt reaktion |
US7884119B2 (en) | 2005-09-07 | 2011-02-08 | Rigel Pharmaceuticals, Inc. | Triazole derivatives useful as Axl inhibitors |
GB0522310D0 (en) | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
US20090228299A1 (en) | 2005-11-09 | 2009-09-10 | The Regents Of The University Of California | Methods and apparatus for context-sensitive telemedicine |
GB0523276D0 (en) | 2005-11-15 | 2005-12-21 | London Bridge Fertility | Chromosomal analysis by molecular karyotyping |
ES2634665T3 (es) | 2005-11-26 | 2017-09-28 | Natera, Inc. | Método y sistema para detectar anormalidades cromosómicas |
WO2007070280A2 (en) | 2005-12-02 | 2007-06-21 | The General Hospital Corporation | Use of deletion polymorphisms to predict, prevent, and manage histoincompatibility |
WO2007070482A2 (en) | 2005-12-14 | 2007-06-21 | Xueliang Xia | Microarray-based preimplantation genetic diagnosis of chromosomal abnormalities |
JP5198284B2 (ja) | 2005-12-22 | 2013-05-15 | キージーン ナムローゼ フェンノートシャップ | 高処理量配列決定技術を使用する転写産物の特徴づけのための改良された戦略 |
PL1981995T5 (pl) | 2006-02-02 | 2019-10-31 | Univ Leland Stanford Junior | Nieinwazyjne genetyczne badania przesiewowe płodu metodą analizy cyfrowej |
WO2007092538A2 (en) | 2006-02-07 | 2007-08-16 | President And Fellows Of Harvard College | Methods for making nucleotide probes for sequencing and synthesis |
WO2007091064A1 (en) | 2006-02-08 | 2007-08-16 | Solexa Limited | End modification to prevent over-representation of fragments |
EP2351858B1 (en) | 2006-02-28 | 2014-12-31 | University of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
US20100184043A1 (en) | 2006-02-28 | 2010-07-22 | University Of Louisville Research Foundation | Detecting Genetic Abnormalities |
CA2647280A1 (en) | 2006-03-13 | 2007-09-20 | Veridex, Llc | Propagation of primary cells |
WO2007112418A2 (en) | 2006-03-28 | 2007-10-04 | Baylor College Of Medicine | Screening for down syndrome |
JP2009072062A (ja) | 2006-04-07 | 2009-04-09 | Institute Of Physical & Chemical Research | 核酸の5’末端を単離するための方法およびその適用 |
US20070243549A1 (en) | 2006-04-12 | 2007-10-18 | Biocept, Inc. | Enrichment of circulating fetal dna |
US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
US7901884B2 (en) | 2006-05-03 | 2011-03-08 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
US7754428B2 (en) | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
EP2602321B1 (en) | 2006-05-31 | 2017-08-23 | Sequenom, Inc. | Methods and compositions for the extraction and amplification of nucleic acid from a sample |
US7981609B2 (en) | 2006-06-09 | 2011-07-19 | The Brigham And Women's Hospital, Inc. | Methods for identifying and using SNP panels |
EP2024513B1 (en) | 2006-06-14 | 2016-10-19 | Verinata Health, Inc | Rare cell analysis using sample splitting and dna tags |
WO2009035447A1 (en) | 2006-06-14 | 2009-03-19 | Living Microsystems, Inc. | Diagnosis of fetal abnormalities by comparative genomic hybridization analysis |
US20080070792A1 (en) | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
WO2007147076A2 (en) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Methods for the diagnosis of fetal abnormalities |
EP2029778B1 (en) | 2006-06-14 | 2018-05-02 | Verinata Health, Inc | Diagnosis of fetal abnormalities |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US20080090239A1 (en) | 2006-06-14 | 2008-04-17 | Daniel Shoemaker | Rare cell analysis using sample splitting and dna tags |
WO2007149791A2 (en) | 2006-06-15 | 2007-12-27 | Stratagene | System for isolating biomolecules from a sample |
CN101501251A (zh) | 2006-06-16 | 2009-08-05 | 塞昆纳姆股份有限公司 | 扩增、检测和定量样品中核酸的方法和组合物 |
US20080182244A1 (en) | 2006-08-04 | 2008-07-31 | Ikonisys, Inc. | Pre-Implantation Genetic Diagnosis Test |
CA2661640A1 (en) | 2006-08-24 | 2008-02-28 | University Of Massachusetts Medical School | Mapping of genomic interactions |
EP2064332B1 (en) | 2006-09-14 | 2012-07-18 | Ibis Biosciences, Inc. | Targeted whole genome amplification method for identification of pathogens |
US20080085836A1 (en) | 2006-09-22 | 2008-04-10 | Kearns William G | Method for genetic testing of human embryos for chromosome abnormalities, segregating genetic disorders with or without a known mutation and mitochondrial disorders following in vitro fertilization (IVF), embryo culture and embryo biopsy |
EP2094838A1 (en) | 2006-10-16 | 2009-09-02 | Cellula, Inc. | Methods and compositions for differential expansion of fetal cells in maternal blood and their use |
US20100184152A1 (en) | 2006-10-23 | 2010-07-22 | Vladislav Sandler | Target-oriented whole genome amplification of nucleic acids |
KR100825367B1 (ko) | 2006-11-07 | 2008-04-28 | 전남대학교산학협력단 | 표지자로서 미토콘드리아 유전자 과변이부위를 이용하는조혈모세포이식 후 생착능 평가방법 및 키트 |
WO2008069906A2 (en) | 2006-11-14 | 2008-06-12 | The Regents Of The University Of California | Digital expression of gene analysis |
WO2008061213A2 (en) | 2006-11-16 | 2008-05-22 | Genentech, Inc. | Genetic variations associated with tumors |
WO2008059578A1 (fr) | 2006-11-16 | 2008-05-22 | Olympus Corporation | Procédé d'amplification pcr multiplex |
WO2008079374A2 (en) | 2006-12-21 | 2008-07-03 | Wang Eric T | Methods and compositions for selecting and using single nucleotide polymorphisms |
WO2008081451A2 (en) | 2007-01-03 | 2008-07-10 | Monaliza Medical Ltd. | Methods and kits for analyzing genetic material of a fetus |
US20080164204A1 (en) | 2007-01-08 | 2008-07-10 | Mehdi Hatamian | Valve for facilitating and maintaining separation of fluids and materials |
BRPI0806565A2 (pt) | 2007-01-11 | 2014-05-06 | Erasmus University Medical Center | Captura de conformação de cromossomo circular |
US20100129792A1 (en) | 2007-02-06 | 2010-05-27 | Gerassimos Makrigiorgos | Direct monitoring and pcr amplification of the dosage and dosage difference between target genetic regions |
WO2008098142A2 (en) | 2007-02-08 | 2008-08-14 | Sequenom, Inc. | Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification |
JP2008209985A (ja) | 2007-02-23 | 2008-09-11 | Canon Inc | データ処理装置、電子文書登録方法、及びコンピュータプログラム |
EP2140386A2 (en) | 2007-03-16 | 2010-01-06 | Gene Security Network | System and method for cleaning noisy genetic data and determining chromsome copy number |
JP2010521156A (ja) | 2007-03-16 | 2010-06-24 | 454 ライフ サイエンシーズ コーポレイション | Hiv薬物耐性バリアントの検出のためのシステムおよび方法 |
CN101641452B (zh) | 2007-03-26 | 2013-10-23 | 塞昆纳姆股份有限公司 | 限制性核酸内切酶增强的多态序列检测 |
JP5262230B2 (ja) | 2007-03-28 | 2013-08-14 | 独立行政法人理化学研究所 | 新規多型検出法 |
ITTO20070307A1 (it) | 2007-05-04 | 2008-11-05 | Silicon Biosystems Spa | Metodo e dispositivo per la diagnosi prenatale non-invasiva |
CA2688155C (en) | 2007-05-31 | 2020-02-11 | The Regents Of The University Of California | High specificity and high sensitivity detection based on steric hindrance & enzyme-related signal amplification |
US8822153B2 (en) | 2007-06-01 | 2014-09-02 | The University Of North Carolina At Chapel Hill | Molecular diagnosis and typing of lung cancer variants |
WO2008157264A2 (en) | 2007-06-15 | 2008-12-24 | Sequenom, Inc. | Combined methods for the detection of chromosomal aneuploidy |
EP2171099A1 (en) | 2007-06-20 | 2010-04-07 | Taag-Genetics SA | Nested multiplex amplification method for identification of multiple biological entities |
US20090023190A1 (en) | 2007-06-20 | 2009-01-22 | Kai Qin Lao | Sequence amplification with loopable primers |
EP2162551B1 (en) | 2007-07-03 | 2017-08-23 | Genaphora LTD. | Chimeric primers for improved nucleic acid amplification reactions |
WO2009009769A2 (en) | 2007-07-11 | 2009-01-15 | Artemis Health, Inc. | Diagnosis of fetal abnormalities using nucleated red blood cells |
US20100112590A1 (en) | 2007-07-23 | 2010-05-06 | The Chinese University Of Hong Kong | Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment |
KR102516709B1 (ko) | 2007-07-23 | 2023-04-03 | 더 차이니즈 유니버시티 오브 홍콩 | 핵산 서열 불균형의 결정 |
KR101376359B1 (ko) | 2007-08-01 | 2014-03-27 | 다나-파버 캔서 인스티튜트 인크. | 표적 서열 강화 |
WO2009019215A1 (en) | 2007-08-03 | 2009-02-12 | Dkfz Deutsches Krebsforschungszentrum | Method for prenatal diagnosis using exosomes and cd24 as a marker |
US20090053719A1 (en) | 2007-08-03 | 2009-02-26 | The Chinese University Of Hong Kong | Analysis of nucleic acids by digital pcr |
WO2009032781A2 (en) | 2007-08-29 | 2009-03-12 | Sequenom, Inc. | Methods and compositions for universal size-specific polymerase chain reaction |
WO2009032779A2 (en) | 2007-08-29 | 2009-03-12 | Sequenom, Inc. | Methods and compositions for the size-specific seperation of nucleic acid from a sample |
US8748100B2 (en) | 2007-08-30 | 2014-06-10 | The Chinese University Of Hong Kong | Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences |
MX2010002556A (es) | 2007-09-07 | 2010-08-02 | Fluidigm Corp | Metodos y sistemas para determinar la variacion del numero de copia. |
CA2697640C (en) | 2007-09-21 | 2016-06-21 | Katholieke Universiteit Leuven | Tools and methods for genetic tests using next generation sequencing |
EP2191012A1 (en) | 2007-09-21 | 2010-06-02 | Streck, Inc. | Nucleic acid isolation in preserved whole blood |
US20100086914A1 (en) | 2008-10-03 | 2010-04-08 | Roche Molecular Systems, Inc. | High resolution, high throughput hla genotyping by clonal sequencing |
CA2701411A1 (en) | 2007-10-16 | 2009-04-23 | F. Hoffmann-La Roche Ag | High resolution, high throughput hla genotyping by clonal sequencing |
WO2009064897A2 (en) | 2007-11-14 | 2009-05-22 | Chronix Biomedical | Detection of nucleic acid sequence variations in circulating nucleic acid in bovine spongiform encephalopathy |
CA2705267C (en) | 2007-11-30 | 2018-07-31 | Ge Healthcare Bio-Sciences Corp. | Method for isolation of genomic dna, rna and proteins from a single sample |
FR2925480B1 (fr) | 2007-12-21 | 2011-07-01 | Gervais Danone Sa | Procede d'enrichissement d'une eau en oxygene par voie electrolytique, eau ou boisson enrichie en oxygene et utilisations |
EP2077337A1 (en) | 2007-12-26 | 2009-07-08 | Eppendorf Array Technologies SA | Amplification and detection composition, method and kit |
US8852864B2 (en) | 2008-01-17 | 2014-10-07 | Sequenom Inc. | Methods and compositions for the analysis of nucleic acids |
EP2245191A1 (en) | 2008-01-17 | 2010-11-03 | Sequenom, Inc. | Single molecule nucleic acid sequence analysis processes and compositions |
ES2703363T3 (es) | 2008-02-01 | 2019-03-08 | Massachusetts Gen Hospital | Uso de microvesículas en el diagnóstico y pronóstico de tumores cerebrales |
EP2245198A1 (en) | 2008-02-04 | 2010-11-03 | Massachusetts Institute of Technology | Selection of nucleic acids by solution hybridization to oligonucleotide baits |
US20110033862A1 (en) | 2008-02-19 | 2011-02-10 | Gene Security Network, Inc. | Methods for cell genotyping |
US20090221620A1 (en) | 2008-02-20 | 2009-09-03 | Celera Corporation | Gentic polymorphisms associated with stroke, methods of detection and uses thereof |
AU2009223671B2 (en) | 2008-03-11 | 2014-11-27 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
CA2718887A1 (en) | 2008-03-19 | 2009-09-24 | Existence Genetics Llc | Genetic analysis |
US8206926B2 (en) | 2008-03-26 | 2012-06-26 | Sequenom, Inc. | Restriction endonuclease enhanced polymorphic sequence detection |
EP2274446B1 (en) | 2008-03-31 | 2015-09-09 | Pacific Biosciences of California, Inc. | Two slow-step polymerase enzyme systems and methods |
CN107385040B (zh) | 2008-04-03 | 2022-02-15 | 艾瑞普特公司 | 用于扩增多个靶标的扩增子拯救多重聚合酶链式反应 |
US20110092763A1 (en) | 2008-05-27 | 2011-04-21 | Gene Security Network, Inc. | Methods for Embryo Characterization and Comparison |
EP2128169A1 (de) | 2008-05-30 | 2009-12-02 | Qiagen GmbH | Verfahren zur Isolierung von kurzkettigen Nukleinsäuren |
ES2754033T3 (es) | 2008-07-21 | 2020-04-15 | Becton Dickinson Co | Dispositivo de separación de fase de densidad |
JP5555453B2 (ja) | 2008-07-24 | 2014-07-23 | スリーエム イノベイティブ プロパティズ カンパニー | 研磨材製品、その製造方法及び使用方法 |
US20100041048A1 (en) | 2008-07-31 | 2010-02-18 | The Johns Hopkins University | Circulating Mutant DNA to Assess Tumor Dynamics |
ES2620431T3 (es) | 2008-08-04 | 2017-06-28 | Natera, Inc. | Métodos para la determinación de alelos y de ploidía |
US8697363B2 (en) | 2008-08-26 | 2014-04-15 | Fluidigm Corporation | Methods for detecting multiple target nucleic acids in multiple samples by use nucleotide tags |
DE102008045705A1 (de) | 2008-09-04 | 2010-04-22 | Macherey, Nagel Gmbh & Co. Kg Handelsgesellschaft | Verfahren zur Gewinnung von kurzer RNA sowie Kit hierfür |
US8586310B2 (en) | 2008-09-05 | 2013-11-19 | Washington University | Method for multiplexed nucleic acid patch polymerase chain reaction |
JP5727375B2 (ja) | 2008-09-16 | 2015-06-03 | セクエノム, インコーポレイテッド | 非侵襲性の出生前診断のために有用な、母体サンプル由来の胎児核酸のメチル化に基づく濃縮のためのプロセスおよび組成物 |
US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
WO2010033652A1 (en) | 2008-09-17 | 2010-03-25 | Ge Healthcare Bio-Sciences Corp. | Method for small rna isolation |
ES2620012T3 (es) | 2008-09-20 | 2017-06-27 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnóstico no invasivo de la aneuploidia fetal por secuenciación |
US9156010B2 (en) | 2008-09-23 | 2015-10-13 | Bio-Rad Laboratories, Inc. | Droplet-based assay system |
US20110301221A1 (en) | 2008-10-10 | 2011-12-08 | Swedish Health Services | Diagnosis, prognosis and treatment of glioblastoma multiforme |
WO2010045617A2 (en) | 2008-10-17 | 2010-04-22 | University Of Louisville Research Foundation | Detecting genetic abnormalities |
EP2364368B1 (en) | 2008-11-07 | 2014-01-15 | Sequenta, Inc. | Methods of monitoring conditions by sequence analysis |
US9506119B2 (en) | 2008-11-07 | 2016-11-29 | Adaptive Biotechnologies Corp. | Method of sequence determination using sequence tags |
US8748103B2 (en) | 2008-11-07 | 2014-06-10 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
JP2012513217A (ja) | 2008-12-22 | 2012-06-14 | セルラ・インコーポレイテッド | 対立遺伝子、ゲノムおよびトランスクリプトームを検出する方法および遺伝子型決定パネル |
US11634747B2 (en) | 2009-01-21 | 2023-04-25 | Streck Llc | Preservation of fetal nucleic acids in maternal plasma |
US8450063B2 (en) | 2009-01-28 | 2013-05-28 | Fluidigm Corporation | Determination of copy number differences by amplification |
ES2649572T3 (es) | 2009-02-18 | 2018-01-12 | Streck Inc. | Conservación de ácidos nucleicos fuera de las células |
CN103911428B (zh) | 2009-03-27 | 2016-02-24 | 生命技术公司 | 用于检测等位基因变体的方法、组合物和试剂盒 |
DK2414547T3 (da) | 2009-04-02 | 2014-06-16 | Fluidigm Corp | Multiprimer-amplifikationsmetode til stregkodning af målnukleinsyrer |
US20100285537A1 (en) | 2009-04-02 | 2010-11-11 | Fluidigm Corporation | Selective tagging of short nucleic acid fragments and selective protection of target sequences from degradation |
EP3211095B1 (en) | 2009-04-03 | 2019-01-02 | Sequenom, Inc. | Nucleic acid preparation compositions and methods |
EP2417270B1 (en) | 2009-04-06 | 2017-09-20 | The Johns Hopkins University | Digital quantification of dna methylation |
US9085798B2 (en) | 2009-04-30 | 2015-07-21 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
US8481699B2 (en) | 2009-07-14 | 2013-07-09 | Academia Sinica | Multiplex barcoded Paired-End ditag (mbPED) library construction for ultra high throughput sequencing |
US20130196862A1 (en) | 2009-07-17 | 2013-08-01 | Natera, Inc. | Informatics Enhanced Analysis of Fetal Samples Subject to Maternal Contamination |
US8563242B2 (en) | 2009-08-11 | 2013-10-22 | The Chinese University Of Hong Kong | Method for detecting chromosomal aneuploidy |
CN101643904B (zh) | 2009-08-27 | 2011-04-27 | 北京北方微电子基地设备工艺研究中心有限责任公司 | 深硅刻蚀装置和深硅刻蚀设备的进气系统 |
WO2011032078A1 (en) | 2009-09-11 | 2011-03-17 | Health Reseach Inc. | Detection of x4 strains of hiv-1 by heteroduplex tracking assay |
CN102575292B (zh) | 2009-09-22 | 2015-07-29 | 霍夫曼-拉罗奇有限公司 | 与疾病相关的kir单元型的测定 |
AU2010298620B2 (en) | 2009-09-24 | 2016-08-11 | Qiagen Gaithersburg Inc. | Compositions, methods, and kits for isolating and analyzing nucleic acids using an anion exchange material |
WO2011041485A1 (en) | 2009-09-30 | 2011-04-07 | Gene Security Network, Inc. | Methods for non-invasive prenatal ploidy calling |
ES2564656T3 (es) | 2009-10-26 | 2016-03-28 | Lifecodexx Ag | Medios y métodos para el diagnóstico no invasivo de la aneuploidía cromosómica |
CA2779695C (en) | 2009-11-05 | 2016-05-24 | The Chinese University Of Hong Kong | Fetal genomic analysis from a maternal biological sample |
JP2013509883A (ja) | 2009-11-06 | 2013-03-21 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 臓器移植患者における移植片拒絶反応の非侵襲的診断方法 |
WO2011057184A1 (en) | 2009-11-09 | 2011-05-12 | Streck, Inc. | Stabilization of rna in and extracting from intact cells within a blood sample |
WO2011066476A1 (en) | 2009-11-25 | 2011-06-03 | Quantalife, Inc. | Methods and compositions for detecting genetic material |
US20120251411A1 (en) | 2009-12-07 | 2012-10-04 | Min-Yong Jeon | Centrifuge tube |
WO2011072086A1 (en) | 2009-12-08 | 2011-06-16 | Hemaquest Pharmaceuticals, Inc. | Methods and low dose regimens for treating red blood cell disorders |
US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
US9315857B2 (en) | 2009-12-15 | 2016-04-19 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse label-tags |
US8574842B2 (en) | 2009-12-22 | 2013-11-05 | The Board Of Trustees Of The Leland Stanford Junior University | Direct molecular diagnosis of fetal aneuploidy |
EP3660165B1 (en) | 2009-12-22 | 2023-01-04 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
CA2786916A1 (en) | 2010-01-15 | 2011-07-21 | The University Of British Columbia | Multiplex amplification for the detection of nucleic acid variations |
GB2485645B (en) | 2010-01-19 | 2012-11-21 | Verinata Health Inc | Improved identification of partial aneuploidies using a normalising sequence |
US20120010085A1 (en) | 2010-01-19 | 2012-01-12 | Rava Richard P | Methods for determining fraction of fetal nucleic acids in maternal samples |
US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
US9323888B2 (en) | 2010-01-19 | 2016-04-26 | Verinata Health, Inc. | Detecting and classifying copy number variation |
US20120270739A1 (en) | 2010-01-19 | 2012-10-25 | Verinata Health, Inc. | Method for sample analysis of aneuploidies in maternal samples |
US20110312503A1 (en) | 2010-01-23 | 2011-12-22 | Artemis Health, Inc. | Methods of fetal abnormality detection |
WO2011100057A2 (en) | 2010-02-09 | 2011-08-18 | Eugene Spier | Methods and compositions for universal detection of nucleic acids |
DK2539472T3 (da) | 2010-02-26 | 2015-08-24 | Hennessy Lori | Hurtig pcr til str genotypebestemmelse |
JP5808349B2 (ja) | 2010-03-01 | 2015-11-10 | カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー | セラノーシスのためのバイオマーカー |
EP2551356B1 (en) | 2010-03-24 | 2017-06-14 | Toppan Printing Co., Ltd. | Method for detecting target base sequence using competitive primer |
US9255291B2 (en) | 2010-05-06 | 2016-02-09 | Bioo Scientific Corporation | Oligonucleotide ligation methods for improving data quality and throughput using massively parallel sequencing |
WO2011140433A2 (en) | 2010-05-07 | 2011-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Measurement and comparison of immune diversity by high-throughput sequencing |
US20140186827A1 (en) | 2010-05-14 | 2014-07-03 | Fluidigm, Inc. | Assays for the detection of genotype, mutations, and/or aneuploidy |
WO2011143659A2 (en) | 2010-05-14 | 2011-11-17 | Fluidigm Corporation | Nucleic acid isolation methods |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20190284623A1 (en) | 2010-05-18 | 2019-09-19 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20190309358A1 (en) | 2010-05-18 | 2019-10-10 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
EP2854057B1 (en) | 2010-05-18 | 2018-03-07 | Natera, Inc. | Methods for non-invasive pre-natal ploidy calling |
WO2013052557A2 (en) | 2011-10-03 | 2013-04-11 | Natera, Inc. | Methods for preimplantation genetic diagnosis by sequencing |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20190323076A1 (en) | 2010-05-18 | 2019-10-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US20130123120A1 (en) | 2010-05-18 | 2013-05-16 | Natera, Inc. | Highly Multiplex PCR Methods and Compositions |
US20140206552A1 (en) | 2010-05-18 | 2014-07-24 | Natera, Inc. | Methods for preimplantation genetic diagnosis by sequencing |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20110301854A1 (en) | 2010-06-08 | 2011-12-08 | Curry Bo U | Method of Determining Allele-Specific Copy Number of a SNP |
US20120190557A1 (en) | 2011-01-25 | 2012-07-26 | Aria Diagnostics, Inc. | Risk calculation for evaluation of fetal aneuploidy |
US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
US20120034603A1 (en) | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
US20130040375A1 (en) | 2011-08-08 | 2013-02-14 | Tandem Diagnotics, Inc. | Assay systems for genetic analysis |
EP2426217A1 (en) | 2010-09-03 | 2012-03-07 | Centre National de la Recherche Scientifique (CNRS) | Analytical methods for cell free nucleic acids and applications |
WO2012042374A2 (en) | 2010-10-01 | 2012-04-05 | Anssi Jussi Nikolai Taipale | Method of determining number or concentration of molecules |
WO2012058316A1 (en) | 2010-10-26 | 2012-05-03 | Stanford University | Non-invasive fetal genetic screening by sequencing analysis |
CN103328654B (zh) | 2010-10-27 | 2017-07-11 | 哈佛学院院长等 | 立足点引物双链体的组合物及其使用方法 |
KR102185244B1 (ko) | 2010-11-30 | 2020-12-02 | 더 차이니즈 유니버시티 오브 홍콩 | 암과 연관된 유전적 또는 분자적 이상들의 검출 |
EP2649199A2 (en) | 2010-12-07 | 2013-10-16 | Stanford University | Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale |
WO2012083250A2 (en) | 2010-12-17 | 2012-06-21 | Celula, Inc. | Methods for screening and diagnosing genetic conditions |
AU2011348100B2 (en) | 2010-12-22 | 2016-08-25 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
KR20210131432A (ko) | 2010-12-30 | 2021-11-02 | 파운데이션 메디신 인코포레이티드 | 종양 샘플의 다유전자 분석의 최적화 |
US20120190021A1 (en) | 2011-01-25 | 2012-07-26 | Aria Diagnostics, Inc. | Detection of genetic abnormalities |
RU2671980C2 (ru) | 2011-02-09 | 2018-11-08 | Натера, Инк. | Способы неинвазивного пренатального установления плоидности |
EP3760732A1 (en) | 2011-02-09 | 2021-01-06 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
GB2488358A (en) | 2011-02-25 | 2012-08-29 | Univ Plymouth | Enrichment of foetal DNA in maternal plasma |
WO2012129363A2 (en) | 2011-03-24 | 2012-09-27 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
JP5863946B2 (ja) | 2011-04-12 | 2016-02-17 | ベリナタ ヘルス インコーポレイテッド | 多型カウントを用いたゲノム画分の分析 |
AU2011365507A1 (en) * | 2011-04-14 | 2013-05-02 | Verinata Health, Inc. | Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies |
EP2754078A4 (en) | 2011-04-14 | 2015-12-02 | Complete Genomics Inc | PROCESSING AND ANALYSIS OF COMPLEX NUCLEIC ACID SEQUENCE DATA |
EP2697397B1 (en) | 2011-04-15 | 2017-04-05 | The Johns Hopkins University | Safe sequencing system |
US9411937B2 (en) * | 2011-04-15 | 2016-08-09 | Verinata Health, Inc. | Detecting and classifying copy number variation |
US9957558B2 (en) | 2011-04-28 | 2018-05-01 | Life Technologies Corporation | Methods and compositions for multiplex PCR |
US8460872B2 (en) | 2011-04-29 | 2013-06-11 | Sequenom, Inc. | Quantification of a minority nucleic acid species |
EP2546361B1 (en) | 2011-07-11 | 2015-06-03 | Samsung Electronics Co., Ltd. | Method of amplifying target nucleic acid with reduced amplification bias and method for determining relative amount of target nucleic acid in sample |
US20130024127A1 (en) | 2011-07-19 | 2013-01-24 | John Stuelpnagel | Determination of source contributions using binomial probability calculations |
GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
CA2848304A1 (en) | 2011-09-09 | 2013-03-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for sequencing a polynucleotide |
JP5536729B2 (ja) | 2011-09-20 | 2014-07-02 | 株式会社ソニー・コンピュータエンタテインメント | 情報処理装置、アプリケーション提供システム、アプリケーション提供サーバ、アプリケーション提供方法、および情報処理方法 |
ES2693672T3 (es) | 2011-09-26 | 2018-12-13 | Qiagen Gmbh | Método rápido para aislar ácidos nucleicos extracelulares |
US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
EP2764458B1 (en) | 2011-10-06 | 2021-04-07 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
AU2012321053B2 (en) | 2011-10-07 | 2018-04-19 | Murdoch Childrens Research Institute | Diagnostic assay for tissue transplantation status |
WO2013078470A2 (en) | 2011-11-22 | 2013-05-30 | MOTIF, Active | Multiplex isolation of protein-associated nucleic acids |
WO2013086352A1 (en) | 2011-12-07 | 2013-06-13 | Chronix Biomedical | Prostate cancer associated circulating nucleic acid biomarkers |
WO2013086464A1 (en) * | 2011-12-07 | 2013-06-13 | The Broad Institute, Inc. | Markers associated with chronic lymphocytic leukemia prognosis and progression |
US20130190653A1 (en) | 2012-01-25 | 2013-07-25 | Angel Gabriel Alvarez Ramos | Device for blood collection from the placenta and the umbilical cord |
EP2814986B1 (en) | 2012-02-14 | 2017-10-25 | Cornell University | Method for relative quantification of nucleic acid sequence, expression, or copy changes, using combined nuclease, ligation, and polymerase reactions |
EP3287531B1 (en) | 2012-02-28 | 2019-06-19 | Agilent Technologies, Inc. | Method for attaching a counter sequence to a nucleic acid sample |
WO2013130848A1 (en) * | 2012-02-29 | 2013-09-06 | Natera, Inc. | Informatics enhanced analysis of fetal samples subject to maternal contamination |
US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
EP2825675B1 (en) | 2012-03-13 | 2017-12-27 | Patel, Abhijit Ajit | Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing |
US10385396B2 (en) | 2012-04-19 | 2019-08-20 | The Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free DNA |
EP2653562A1 (en) | 2012-04-20 | 2013-10-23 | Institut Pasteur | Anellovirus genome quantification as a biomarker of immune suppression |
US9487828B2 (en) | 2012-05-10 | 2016-11-08 | The General Hospital Corporation | Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence |
AU2013266394B2 (en) | 2012-05-21 | 2019-03-14 | The Scripps Research Institute | Methods of sample preparation |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
CN104350152B (zh) | 2012-06-01 | 2017-08-11 | 欧米伽生物技术公司 | 选择性核酸片段回收 |
US11261494B2 (en) * | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
WO2014004726A1 (en) | 2012-06-26 | 2014-01-03 | Caifu Chen | Methods, compositions and kits for the diagnosis, prognosis and monitoring of cancer |
US20150011396A1 (en) | 2012-07-09 | 2015-01-08 | Benjamin G. Schroeder | Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing |
CA2878246C (en) | 2012-07-20 | 2022-01-11 | Verinata Health, Inc. | Detecting and classifying copy number variation in a cancer genome |
EP2877598A1 (en) * | 2012-07-24 | 2015-06-03 | Pharmacyclics, Inc. | Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk) |
CA2877493C (en) * | 2012-07-24 | 2020-08-25 | Natera, Inc. | Highly multiplex pcr methods and compositions |
US10993418B2 (en) | 2012-08-13 | 2021-05-04 | Life Genetics Lab, Llc | Method for measuring tumor burden in patient derived xenograft (PDX) mice |
JP2015528443A (ja) * | 2012-08-15 | 2015-09-28 | ユニヴェルシテ・ドゥ・モントリオール | 新規マイナー組織適合抗原を同定するための方法 |
US20140051585A1 (en) | 2012-08-15 | 2014-02-20 | Natera, Inc. | Methods and compositions for reducing genetic library contamination |
US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
WO2014035986A1 (en) | 2012-08-28 | 2014-03-06 | Akonni Biosystems Inc. | Method and kit for purifying nucleic acids |
US20140066317A1 (en) | 2012-09-04 | 2014-03-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US20140065621A1 (en) | 2012-09-04 | 2014-03-06 | Natera, Inc. | Methods for increasing fetal fraction in maternal blood |
CA2883901C (en) | 2012-09-04 | 2023-04-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
CN107892719B (zh) | 2012-10-04 | 2022-01-14 | 达纳-法伯癌症研究所公司 | 人单克隆抗-pd-l1抗体和使用方法 |
US9669405B2 (en) | 2012-10-22 | 2017-06-06 | The Regents Of The University Of California | Sterilizable photopolymer serum separator |
EP2728014B1 (en) | 2012-10-31 | 2015-10-07 | Genesupport SA | Non-invasive method for detecting a fetal chromosomal aneuploidy |
US20220307086A1 (en) | 2012-11-21 | 2022-09-29 | Natera, Inc. | Methods for simultaneous amplification of target loci |
EP2943590A4 (en) | 2013-01-13 | 2017-02-15 | Unitaq Bio | Methods and compositions for pcr using blocked and universal primers |
WO2014122288A1 (en) | 2013-02-08 | 2014-08-14 | Qiagen Gmbh | Method for separating dna by size |
US9982255B2 (en) | 2013-03-11 | 2018-05-29 | Kailos Genetics, Inc. | Capture methodologies for circulating cell free DNA |
CA2902167A1 (en) | 2013-03-15 | 2014-09-25 | Abbott Molecular Inc. | Method for amplification and assay of rna fusion gene variants, method of distinguishing same and related primers, probes, and kits |
US10385394B2 (en) | 2013-03-15 | 2019-08-20 | The Translational Genomics Research Institute | Processes of identifying and characterizing X-linked disorders |
CA3156663A1 (en) | 2013-03-15 | 2014-09-18 | Verinata Health, Inc. | Generating cell-free dna libraries directly from blood |
EP3882362B1 (en) | 2013-03-15 | 2024-05-08 | Guardant Health, Inc. | Methods for sequencing of cell free polynucleotides |
EP2971152B1 (en) | 2013-03-15 | 2018-08-01 | The Board Of Trustees Of The Leland Stanford Junior University | Identification and use of circulating nucleic acid tumor markers |
MX2015012733A (es) | 2013-03-15 | 2016-06-21 | Immucor Gti Diagnostics Inc | Metodos y composiciones para evaluar el estado renal usando adn libre de celulas de la orina. |
US10072298B2 (en) | 2013-04-17 | 2018-09-11 | Life Technologies Corporation | Gene fusions and gene variants associated with cancer |
LT3004388T (lt) | 2013-05-29 | 2019-01-25 | Chronix Biomedical | Donoro ne ląstelinės dnr aptikimas ir jos kiekio nustatymas organo transplantanto recipientų apytakoje |
US10577655B2 (en) | 2013-09-27 | 2020-03-03 | Natera, Inc. | Cell free DNA diagnostic testing standards |
US11694764B2 (en) | 2013-09-27 | 2023-07-04 | University Of Washington | Method for large scale scaffolding of genome assemblies |
WO2015048535A1 (en) | 2013-09-27 | 2015-04-02 | Natera, Inc. | Prenatal diagnostic resting standards |
IL285106B (en) | 2013-11-07 | 2022-09-01 | Univ Leland Stanford Junior | Clean nucleic acids are suitable for analyzing the human microbiome and its parts |
DK3077539T3 (en) | 2013-12-02 | 2018-11-19 | Personal Genome Diagnostics Inc | Procedure for evaluating minority variations in a sample |
EP3524694B1 (en) | 2013-12-28 | 2020-07-15 | Guardant Health, Inc. | Methods and systems for detecting genetic variants |
SG11201605344YA (en) | 2013-12-30 | 2016-07-28 | Atreca Inc | Analysis of nucleic acids associated with single cells using nucleic acid barcodes |
CN106661612A (zh) | 2014-01-27 | 2017-05-10 | 通用医疗公司 | 制备用于测序的核酸的方法 |
JP6494045B2 (ja) | 2014-02-11 | 2019-04-03 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 標的シーケンシングおよびuidフィルタリング |
EP3114231B1 (en) | 2014-03-03 | 2019-01-02 | Swift Biosciences, Inc. | Enhanced adaptor ligation |
PL3117012T3 (pl) | 2014-03-14 | 2019-08-30 | Caredx, Inc. | Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu |
EP3825421B1 (en) | 2014-03-25 | 2022-06-22 | Quest Diagnostics Investments Incorporated | Detection of gene fusions by intragenic differential expression (ide) using average cycle thresholds |
WO2015164432A1 (en) | 2014-04-21 | 2015-10-29 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
CN113774132A (zh) | 2014-04-21 | 2021-12-10 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
US20180173846A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
EP3161149B1 (en) | 2014-06-27 | 2020-06-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods employing circulating dna and mirna as biomarkers for female infertility |
EP3164489B1 (en) | 2014-07-03 | 2020-05-13 | Rhodx, Inc. | Tagging and assessing a target sequence |
AU2015289027B2 (en) | 2014-07-17 | 2021-08-19 | Qiagen Gmbh | Method for isolating RNA with high yield |
GB201412834D0 (en) | 2014-07-18 | 2014-09-03 | Cancer Rec Tech Ltd | A method for detecting a genetic variant |
CA2955367C (en) | 2014-07-18 | 2021-11-30 | Illumina, Inc. | Non-invasive prenatal diagnosis of fetal genetic condition using cellular dna and cell free dna |
AU2015330844B2 (en) | 2014-10-08 | 2022-02-03 | Cornell University | Method for identification and quantification of nucleic acid expression, splice variant, translocation, copy number, or methylation changes |
EP3209797B1 (en) | 2014-10-20 | 2018-12-05 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for screening a subject for a cancer |
CN107405540A (zh) | 2014-10-24 | 2017-11-28 | 雅培分子公司 | 小核酸的富集 |
EP3218519B1 (en) | 2014-11-11 | 2020-12-02 | BGI Shenzhen | Multi-pass sequencing |
EP3227462B1 (en) | 2014-12-01 | 2020-04-22 | The Broad Institute, Inc. | Method for in situ determination of nucleic acid proximity |
WO2016109604A2 (en) | 2014-12-29 | 2016-07-07 | InnoGenomics Technologies, LLC | Multiplexed assay for quantitating and assessing integrity of cell-free dna in biological fluids for cancer diagnosis, prognosis, and surveillance |
GB201501907D0 (en) | 2015-02-05 | 2015-03-25 | Technion Res & Dev Foundation | System and method for single cell genetic analysis |
WO2016123698A1 (en) | 2015-02-06 | 2016-08-11 | Uti Limited Partnership | Diagnostic assay for post-transplant assessment of potential rejection of donor organs |
WO2016138080A1 (en) | 2015-02-24 | 2016-09-01 | Trustees Of Boston University | Protection of barcodes during dna amplification using molecular hairpins |
ES2906221T3 (es) | 2015-02-27 | 2022-04-13 | Becton Dickinson Co | Métodos para el marcado con códigos de barras de ácidos nucleicos para secuenciación |
ES2934982T3 (es) | 2015-03-30 | 2023-02-28 | Becton Dickinson Co | Métodos para la codificación con códigos de barras combinatorios |
KR101850437B1 (ko) | 2015-04-14 | 2018-04-20 | 이원다이애그노믹스(주) | 차세대 염기서열 분석기법을 이용한 장기 이식 거부 반응 예측 방법 |
EP3286326A1 (en) | 2015-04-23 | 2018-02-28 | Cellular Research, Inc. | Methods and compositions for whole transcriptome amplification |
US10844428B2 (en) | 2015-04-28 | 2020-11-24 | Illumina, Inc. | Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS) |
US20180142296A1 (en) | 2015-04-30 | 2018-05-24 | Medical College Of Wisconsin, Inc. | Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing cell-free dna |
WO2016183106A1 (en) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Methods and compositions for determining ploidy |
US20180291365A1 (en) | 2015-06-05 | 2018-10-11 | Qiagen Gmbh | Method for separating dna by size |
US20160371428A1 (en) | 2015-06-19 | 2016-12-22 | Natera, Inc. | Systems and methods for determining aneuploidy risk using sample fetal fraction |
GB201516047D0 (en) | 2015-09-10 | 2015-10-28 | Cancer Rec Tech Ltd | Method |
US20180282796A1 (en) | 2015-09-29 | 2018-10-04 | Ludwig Institute For Cancer Research Ltd | Typing and Assembling Discontinuous Genomic Elements |
AU2016341198B2 (en) | 2015-10-19 | 2023-03-09 | Dovetail Genomics, Llc | Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection |
WO2017079593A1 (en) | 2015-11-04 | 2017-05-11 | Atreca, Inc. | Combinatorial sets of nucleic acid barcodes for analysis of nucleic acids associated with single cells |
US20170145475A1 (en) | 2015-11-20 | 2017-05-25 | Streck, Inc. | Single spin process for blood plasma separation and plasma composition including preservative |
CN105986030A (zh) | 2016-02-03 | 2016-10-05 | 广州市基准医疗有限责任公司 | 甲基化dna检测方法 |
EP4071250A1 (en) | 2016-03-22 | 2022-10-12 | Myriad Women's Health, Inc. | Combinatorial dna screening |
WO2017173039A1 (en) | 2016-03-30 | 2017-10-05 | Covaris, Inc. | Extraction of cfdna from biological samples |
CA3057717A1 (en) | 2016-04-01 | 2017-10-05 | Uti Limited Partnership | Plasma derived cell-free mitochondrial deoxyribonucleic acid |
EP3443066A4 (en) | 2016-04-14 | 2019-12-11 | Guardant Health, Inc. | EARLY DETECTION METHODS FOR CANCER |
ES2913468T3 (es) | 2016-04-15 | 2022-06-02 | Natera Inc | Métodos para la detección del cáncer de pulmón. |
WO2017190106A1 (en) | 2016-04-29 | 2017-11-02 | Medical College Of Wisconsin, Inc. | Multiplexed optimized mismatch amplification (moma)-target number |
EP3910068A1 (en) | 2016-05-24 | 2021-11-17 | The Translational Genomics Research Institute | Molecular tagging methods and sequencing libraries |
EP3464626B1 (en) | 2016-05-27 | 2022-04-06 | Sequenom, Inc. | Methods for detecting genetic variations |
US20190185913A1 (en) | 2016-07-01 | 2019-06-20 | Natera, Inc. | Compositions and methods for detection of nucleic acid mutations |
BR112019000296A2 (pt) | 2016-07-06 | 2019-04-16 | Guardant Health, Inc. | métodos para a determinação de perfil de fragmentome de ácidos nucleicos livres de célula |
US11485996B2 (en) | 2016-10-04 | 2022-11-01 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
EP3535413A1 (en) | 2016-11-02 | 2019-09-11 | The Medical College of Wisconsin, Inc. | Methods for assessing risk using total and specific cell-free dna |
GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
US11107021B2 (en) | 2016-11-06 | 2021-08-31 | Microsoft Technology Licensing, Llc | Presenting and manipulating task items |
CN117056774A (zh) | 2016-11-08 | 2023-11-14 | 贝克顿迪金森公司 | 用于细胞标记分类的方法 |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
US10920273B2 (en) | 2017-01-17 | 2021-02-16 | Life Technologies Corporation | Compositions and methods for immune repertoire sequencing |
WO2018156418A1 (en) | 2017-02-21 | 2018-08-30 | Natera, Inc. | Compositions, methods, and kits for isolating nucleic acids |
CN110945144A (zh) | 2017-06-20 | 2020-03-31 | 威斯康星州立大学医学院 | 利用无细胞dna的移植患者监测 |
CA3067634A1 (en) | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | Assessing conditions in transplant subjects using donor-specific cell-free dna |
WO2018237075A1 (en) | 2017-06-20 | 2018-12-27 | The Medical College Of Wisconsin, Inc. | ASSESSING THE RISK OF GRAFT COMPLICATION WITH TOTAL ACELLULAR DNA |
MX2020001575A (es) | 2017-08-07 | 2020-11-18 | Univ Johns Hopkins | Materiales y métodos para evaluar y tratar el cáncer. |
EP3676399B1 (en) | 2017-09-01 | 2022-05-11 | Life Technologies Corporation | Compositions and methods for immune repertoire sequencing |
US11091800B2 (en) | 2017-09-20 | 2021-08-17 | University Of Utah Research Foundation | Size-selection of cell-free DNA for increasing family size during next-generation sequencing |
US20210269879A1 (en) | 2017-12-14 | 2021-09-02 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
CN111699269A (zh) | 2018-01-12 | 2020-09-22 | 纳特拉公司 | 新引物及其用途 |
WO2019161244A1 (en) | 2018-02-15 | 2019-08-22 | Natera, Inc. | Methods for isolating nucleic acids with size selection |
GB201819134D0 (en) | 2018-11-23 | 2019-01-09 | Cancer Research Tech Ltd | Improvements in variant detection |
JP2021520816A (ja) | 2018-04-14 | 2021-08-26 | ナテラ, インコーポレイテッド | 循環腫瘍dnaの個別化された検出を用いる癌検出およびモニタリングの方法 |
EP3807884A1 (en) | 2018-06-12 | 2021-04-21 | Natera, Inc. | Methods and systems for calling mutations |
BR112020027023A2 (pt) | 2018-07-03 | 2021-04-06 | Natera, Inc. | Métodos para detecção de dna livre de células derivado de doador |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
BR112021000409A2 (pt) | 2018-07-12 | 2021-04-06 | Twinstrand Biosciences, Inc. | Métodos e reagentes para caracterizar edição genômica, expansão clonal e aplicações associadas |
EP3824470A1 (en) | 2018-07-17 | 2021-05-26 | Natera, Inc. | Methods and systems for calling ploidy states using a neural network |
WO2020041449A1 (en) | 2018-08-21 | 2020-02-27 | Zymo Research Corporation | Methods and compositions for tracking sample quality |
WO2020076957A1 (en) | 2018-10-09 | 2020-04-16 | Tai Diagnostics, Inc. | Cell lysis assay for cell-free dna analysis |
WO2020106897A1 (en) | 2018-11-20 | 2020-05-28 | Alex Brandt | Methods and materials for detecting salmonella in beef |
BR112021009706A2 (pt) | 2018-11-21 | 2021-08-17 | Karius, Inc. | detecção e predição de doença infecciosa |
EP3899030A2 (en) | 2018-12-17 | 2021-10-27 | Natera, Inc. | Methods for analysis of circulating cells |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
WO2020214547A1 (en) | 2019-04-15 | 2020-10-22 | Natera, Inc. | Improved liquid biopsy using size selection |
WO2020247263A1 (en) | 2019-06-06 | 2020-12-10 | Natera, Inc. | Methods for detecting immune cell dna and monitoring immune system |
WO2021055968A1 (en) | 2019-09-20 | 2021-03-25 | Natera Inc. | Methods for assessing graft suitability for transplantation |
CA3180334A1 (en) | 2020-05-29 | 2021-12-02 | Natera, Inc. | Methods for detection of donor-derived cell-free dna |
US20230257816A1 (en) | 2020-07-13 | 2023-08-17 | Aoy Tomita Mitchell | Methods for making treatment management decisions in transplant subjects and assessing transplant risks with threshold values |
WO2022197864A1 (en) | 2021-03-18 | 2022-09-22 | Natera, Inc. | Methods for determination of transplant rejection |
-
2015
- 2015-04-21 CN CN202110905394.5A patent/CN113774132A/zh active Pending
- 2015-04-21 CN CN201910135027.4A patent/CN109971852A/zh active Pending
- 2015-04-21 RU RU2016141308A patent/RU2717641C2/ru active
- 2015-04-21 EP EP21193128.2A patent/EP3957749A1/en not_active Withdrawn
- 2015-04-21 AU AU2015249846A patent/AU2015249846B2/en active Active
- 2015-04-21 CN CN201580033190.XA patent/CN106460070B/zh active Active
- 2015-04-21 EP EP19159999.2A patent/EP3561075A1/en active Pending
- 2015-04-21 US US14/692,703 patent/US10179937B2/en active Active
- 2015-04-21 EP EP15718754.3A patent/EP3134541B1/en active Active
- 2015-04-21 CA CA2945962A patent/CA2945962C/en active Active
- 2015-04-21 JP JP2016563812A patent/JP6659575B2/ja active Active
-
2017
- 2017-06-15 HK HK17105964.2A patent/HK1232260A1/zh unknown
-
2018
- 2018-02-15 US US15/898,145 patent/US11319595B2/en active Active
- 2018-06-21 US US16/014,961 patent/US11486008B2/en active Active
-
2019
- 2019-02-28 US US16/288,462 patent/US11371100B2/en active Active
- 2019-02-28 US US16/288,416 patent/US11408037B2/en active Active
- 2019-02-28 US US16/288,351 patent/US11319596B2/en active Active
- 2019-03-20 US US16/359,917 patent/US11414709B2/en active Active
- 2019-04-30 US US16/399,941 patent/US20190256931A1/en not_active Abandoned
-
2020
- 2020-01-27 JP JP2020010542A patent/JP6994058B2/ja active Active
- 2020-01-27 JP JP2020011048A patent/JP2020072739A/ja active Pending
- 2020-01-27 JP JP2020010558A patent/JP2020072735A/ja active Pending
- 2020-01-27 JP JP2020010659A patent/JP6994059B2/ja active Active
- 2020-01-27 JP JP2020010580A patent/JP7030860B2/ja active Active
- 2020-01-27 JP JP2020010765A patent/JP2020072738A/ja active Pending
-
2021
- 2021-07-27 AU AU2021209221A patent/AU2021209221B2/en active Active
- 2021-12-08 JP JP2021199357A patent/JP2022028950A/ja active Pending
- 2021-12-08 JP JP2021199347A patent/JP2022028949A/ja active Pending
-
2022
- 2022-01-05 US US17/568,854 patent/US20220154290A1/en active Pending
- 2022-02-22 JP JP2022025293A patent/JP7362805B2/ja active Active
- 2022-03-11 US US17/692,469 patent/US20220213561A1/en active Pending
- 2022-03-28 AU AU2022202083A patent/AU2022202083B2/en active Active
- 2022-05-06 US US17/738,354 patent/US11530454B2/en active Active
- 2022-10-04 US US17/959,543 patent/US20230042405A1/en active Pending
-
2023
- 2023-02-20 US US18/111,790 patent/US20230242998A1/en active Pending
- 2023-11-06 JP JP2023189080A patent/JP2024001359A/ja active Pending
-
2024
- 2024-05-13 AU AU2024203154A patent/AU2024203154A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2016141308A (ru) | Обнаружение мутаций и плоидности в хромосомных сегментах | |
Liu et al. | Interrogating the “unsequenceable” genomic trinucleotide repeat disorders by long-read sequencing | |
Tang et al. | Profiling of short-tandem-repeat disease alleles in 12,632 human whole genomes | |
Bansal et al. | Accurate detection and genotyping of SNPs utilizing population sequencing data | |
McElhoe et al. | Development and assessment of an optimized next-generation DNA sequencing approach for the mtgenome using the Illumina MiSeq | |
Stewart et al. | A comprehensive map of mobile element insertion polymorphisms in humans | |
Oey et al. | Genetic and epigenetic variation among inbred mouse littermates: identification of inter-individual differentially methylated regions | |
Chen et al. | PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data | |
Zhang et al. | Developmental validation of a custom panel including 273 SNPs for forensic application using Ion Torrent PGM | |
US20160232291A1 (en) | Systems and methods for determining structural variation and phasing using variant call data | |
US20190348149A1 (en) | Validation methods and systems for sequence variant calls | |
JP2019507585A5 (ru) | ||
Faye et al. | Re-ranking sequencing variants in the post-GWAS era for accurate causal variant identification | |
FI2557517T3 (fi) | Nukleiinihapposekvenssiepätasapainon määrittäminen | |
Hoberman et al. | A probabilistic approach for SNP discovery in high-throughput human resequencing data | |
US10192024B2 (en) | System and method for generation and use of optimal nucleotide flow orders | |
Natsoulis et al. | A flexible approach for highly multiplexed candidate gene targeted resequencing | |
Gillingham et al. | A novel workflow to improve genotyping of multigene families in wildlife species: An experimental set‐up with a known model system | |
JP6858783B2 (ja) | 一塩基多型及びインデルの複対立遺伝子遺伝子型決定 | |
Ahsan et al. | A survey of algorithms for the detection of genomic structural variants from long-read sequencing data | |
Yang et al. | The next generation of complex lung genetic studies | |
Coetzee et al. | A systematic approach to understand the functional consequences of non-protein coding risk regions | |
US20210366575A1 (en) | Methods and systems for detection and phasing of complex genetic variants | |
Gabaldón et al. | Whole-Genome Sequencing Recommendations | |
Giardina et al. | In silico and in vitro comparative analysis to select, validate and test SNPs for human identification |